Depression medications

ANTIDEPRESSANTS

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints MRI_NONSEL SSRI MAOI_NONSEL MAOI_A OTHER_ANTIDEPRESSANTS	180400
6. Filter based on genotype QC (FinnGen only)	161806

Control definitions (FinnGen only)

Control exclude: NEURO_COMORBIDITIES

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	ANTIDEPRESSANTS
CONTROL_EXCLUDE	NEURO_COMORBIDITIES
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	MRI_NONSEL\|SSRI\|MAOI_NONSEL\|MAOI_A\|OTHER_ANTIDEPRESSANTS
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Depression medications based on the number of shared cases.

Similar with more cases:

Any prescribed medicine buy

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	1301037	797631	495459
Only index persons	1186033	738521	447512
Unadjusted period prevalence (%)
Whole population	19.33	22.85	13.84
Only index persons	23.35	27.15	17.08
Median age at first event (years)
Whole population	45.17	45.51	44.51
Only index persons	43.34	43.69	42.76

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	161806	106193	55613
Unadjusted period prevalence (%)	33.51	37.70	25.50
Median age at first event (years)	45.05	42.71	49.54

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
19935: Matched controls
100192

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

IGV01

NOMESCO Finland

Psychiatric network contact

246.0

321.2

432

SPAT1249

SPAT

Treatment-related counselling outside office

1.9

319.8

6860

21800

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

14.8

319.5

451

156

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.5

319.1

2795

6218

F10.25

ICD-10 Finland

Alcohol dependence continuous use

22.1

318.9

393

F42.2

ICD-10 Finland

Mixed obsessional thoughts and acts

59.5

318.0

326

SPAT1301

SPAT

No procedures

2.0

316.7

4882

13807

P01AB01

ATC

metronidazole; oral, rectal

1.9

315.3

6552

20580

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

+∞

315.0

402

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

2045.8

314.1

404

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

76.3

314.1

314

M54.4

ICD-10 Finland

Lumbago with sciatica

2.3

313.0

3184

7592

J01DB01

ATC

cefalexin; oral

2.0

312.5

15672

64953

PHD99

NOMESCO Finland

Resection of other vein

2024.9

310.9

400

WX290

NOMESCO Finland

Other blockage of nerve

1.8

310.8

10996

40746

M03BC01

ATC

orphenadrine (citrate); systemic

2.1

310.7

4071

10803

I47.1

ICD-10 Finland

Supraventricular tachycardia

20.2

309.0

391

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

6.7

308.6

689

531

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

3.6

308.5

1346

1974

XA800

NOMESCO Finland

Neuropsychological investigation

6.5

308.0

708

566

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

122.3

307.7

335

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

13.1

307.7

535

211

A06AD11

ATC

lactulose; oral

4.9

307.7

1502

1629

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

857.6

307.7

1857

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

32.4

307.7

404

WX110

NOMESCO Finland

Infiltration anesthesia

2.0

307.7

14489

56733

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

9.6

307.7

655

355

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

10.8

307.7

1431

712

P29

ICPC

Psychological sympt/compl other

7.0

307.7

2958

2419

N06AX21

ATC

duloxetine; oral

32.9

307.7

3725

694

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

4.0

307.7

1437

1911

N05AN01

ATC

lithium; oral

229.2

307.7

704

N06AX05

ATC

trazodone; oral

92.7

307.7

643

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.4

307.7

3110

7109

L17

ICPC

Foot/toe symptom/complaint

2.2

307.7

5145

13652

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

456.6

307.7

531

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

6.8

307.7

2414

1998

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

166.7

307.7

422

A10BJ06

ATC

semaglutide; parenteral

+∞

307.7

684

A10BJ02

ATC

liraglutide; parenteral

63.5

307.7

360

F60.9

ICD-10 Finland

Personality disorder, unspecified

79.5

307.7

388

D64.9

ICD-10 Finland

Anaemia, unspecified

8.0

307.7

758

494

N06AB03

ATC

fluoxetine; oral

45.2

307.7

3837

526

WZC00

NOMESCO Finland

Treatment plan or consultation

2.1

307.7

6563

19081

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

3.6

307.7

1708

2511

A01

ICPC

Pain general/multiple sites

4.0

307.7

1676

2257

M79.7

ICD-10 Finland

Fibromyalgia

10.6

307.7

717

352

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

47.5

307.7

1141

128

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.0

307.7

7284

22098

C09AA05

ATC

ramipril; oral

5.7

307.7

1839

1744

L03

ICPC

Low back symptom/complaint

2.1

307.7

5720

15861

N05CD07

ATC

temazepam; oral

15.9

307.7

1405

476

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.3

307.7

2060

3376

N05AH04

ATC

quetiapine; oral

33.1

307.7

7074

1640

N03AG01

ATC

valproic acid; systemic, rectal

13.0

307.7

1459

605

M54.5

ICD-10 Finland

Low back pain

2.1

307.7

7179

21050

N02BF01

ATC

gabapentin; oral

4.3

307.7

1782

2212

N05AX08

ATC

risperidone; systemic

42.8

307.7

1962

255

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

3.4

307.7

1798

2829

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

18.2

307.7

512

145

N06AX22

ATC

agomelatine; oral

131.5

307.7

852

B01AB05

ATC

enoxaparin; parenteral

2.6

307.7

3378

7401

A10AE04

ATC

insulin glargine; parenteral

83.3

307.7

1053

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

11.9

307.7

1788

822

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

95.8

307.7

823

N05AD01

ATC

haloperidol; systemic

33.1

307.7

457

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

27.0

307.7

1368

273

N06AX26

ATC

vortioxetine; oral

83.0

307.7

3528

259

A10BK01

ATC

dapagliflozin; oral

198.4

307.7

723

F32.1

ICD-10 Finland

Moderate depressive episode

19.7

307.7

2598

755

OAB50, ,

SPAT

7.8

307.7

882

594

XF404

NOMESCO Finland

Ambulatory ECG

9.6

307.7

707

384

IHZ04, ,

SPAT

11.2

307.7

588

271

N06BA04

ATC

methylphenidate; oral

14.8

307.7

1661

612

A04

ICPC

Weakness/tiredness general

3.0

307.7

3219

6052

ZY000

NOMESCO Finland

Hospital inpatient

147.3

307.7

402

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.5

307.7

3993

9178

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1027.1

307.7

610

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

6.7

307.7

845

660

Z2221

NOMESCO Finland

Medical doctor

2.1

307.7

4222

11147

C03DA01

ATC

spironolactone; oral

6.0

307.7

929

812

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

12.7

307.7

1580

672

C08CA01

ATC

amlodipine; oral

3.6

307.7

3437

5473

R51.80

ICD-10 Finland

Headache

2.9

307.7

3576

7118

T86

ICPC

Hypothyroidism/myxoedema

32.6

307.7

500

F32.9

ICD-10 Finland

Depressive episode, unspecified

38.9

307.7

5635

1005

ZYC01

NOMESCO Finland

Remote contact by phone

7.1

307.7

1342

1009

C07AA05

ATC

propranolol; systemic

6.1

307.7

5432

5763

P74

ICPC

Anxiety disorder/anxiety state

15.2

307.7

1923

697

R07.4

ICD-10 Finland

Chest pain, unspecified

3.2

307.7

3909

7185

L28

ICPC

Limited function/disability (L)

3.4

307.7

1929

3086

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

166.0

307.7

1355

A28

ICPC

Limited function/disability NOS

5.5

307.7

1366

1329

130

Kela drug reimbursment

Malignant tumour

+∞

307.7

444

331

Kela drug reimbursment

Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine

24.6

307.7

525

110

OAB93, ,

SPAT

3.7

307.7

1983

2913

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

26.4

307.7

612

120

C10AX09

ATC

ezetimibe; oral

4.7

307.7

1489

1679

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.9

307.7

8011

26669

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

3.0

307.7

1950

3458

R03AC02

ATC

salbutamol; inhalant

2.1

307.7

10561

35097

B01AC04

ATC

clopidogrel; oral

15.6

307.7

884

297

N05AA02

ATC

levomepromazine; systemic

125.5

307.7

974

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

5.1

307.7

1046

1071

F31

ICD-10 Finland

Bipolar affective disorder

151.8

307.7

385

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

1104.3

307.7

440

A02BC01

ATC

omeprazole; systemic

2.4

307.7

3907

9298

N04AA02

ATC

biperiden; systemic

56.2

307.7

373

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

104.6

307.7

895

I83.9

ICD-10 Finland

Varicose veins of lower extremities without ulcer or inflammation

8.4

307.7

681

422

SPAT1243

SPAT

Psychiatric/psychological examination

9.9

307.7

948

505

N05BA04

ATC

oxazepam; oral

14.0

307.7

7318

3981

I50.9

ICD-10 Finland

Heart failure, unspecified

160.7

307.7

499

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

27.6

307.7

1211

234

JN4BD

NOMESCO Finland

Extensive body CT

7.3

307.7

740

529

P03

ICPC

Feeling depressed

10.4

307.7

4472

2702

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

+∞

307.7

686

N06AX03

ATC

mianserin; oral

49.1

307.7

905

A49.9

ICD-10 Finland

Bacterial infection, unspecified

5.5

307.7

1024

984

207

Kela drug reimbursment

Chronic arrhythmias

310.3

307.7

599

N06AB06

ATC

sertraline; oral

57.5

307.7

4793

549

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

49.9

307.7

1659

182

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

+∞

307.7

472

SPAT1310

SPAT

Counselling related to known health issue

2.1

307.7

5463

15371

215

Kela drug reimbursment

Diabetes, non-insulin-treated

+∞

307.7

2714

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

8.3

307.7

1535

992

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

576.0

307.7

877

N03AX09

ATC

lamotrigine; oral

29.9

307.7

1831

338

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

11.2

307.7

1264

602

H03AA01

ATC

levothyroxine sodium; systemic

28.6

307.7

3226

672

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

4.7

307.7

1071

1206

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

159.6

307.7

1110

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.7

307.7

6476

11666

F41.1

ICD-10 Finland

Generalized anxiety disorder

19.4

307.7

2364

690

TPH07

NOMESCO Finland

Cathetrisation of artery

6.2

307.7

954

810

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.3

307.7

7344

20098

A02BC05

ATC

esomeprazole; systemic

2.3

307.7

6362

17151

N06AG02

ATC

moclobemide; oral

53.6

307.7

828

I48

ICD-10 Finland

Atrial fibrillation and flutter

83.6

307.7

860

C10AA05

ATC

atorvastatin; oral

3.0

307.7

3942

7714

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

160.2

307.7

2750

100

N06CA01

ATC

amitriptyline and psycholeptics; systemic

6.4

307.7

1574

1332

Z71.8

ICD-10 Finland

Other specified counselling

2.2

307.7

7017

19697

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

377.5

307.7

584

AA1AD

NOMESCO Finland

CT of head and brain

4.4

307.7

3589

4766

R5140

NOMESCO Finland

Monitoring the use of the aid

3.8

307.7

1564

2200

N02AX02

ATC

tramadol; systemic, rectal

2.9

307.7

6797

15089

ZXE10

NOMESCO Finland

More than one and less than three hours

2.4

307.7

4846

11727

C10AA01

ATC

simvastatin; oral

3.2

307.7

2850

4931

N05BA02

ATC

chlordiazepoxide; systemic

28.6

307.7

374

UJF32

NOMESCO Finland

Coloscopy

2.8

307.7

2948

5926

N02AJ06

ATC

codeine and paracetamol; systemic

2.2

307.7

8044

23710

SPAT1262

SPAT

Handing over of treatment supplies

7.5

307.7

1850

1340

G47.3

ICD-10 Finland

Sleep apnoea

3.5

307.7

4067

6761

IHZ05, ,

SPAT

5.6

307.7

1754

1704

WX402

NOMESCO Finland

General anaesthesia

2.5

307.7

3550

8120

XF400

NOMESCO Finland

ECG with 12 standard connections

4.9

307.7

1671

1829

F20.9

ICD-10 Finland

Schizophrenia, unspecified

1285.8

307.7

509

SPAT1307

SPAT

Psychosocial counselling and guidance

4.5

307.7

2221

2693

JN4AD

NOMESCO Finland

Body CT examination

8.0

307.7

877

574

F41.3

ICD-10 Finland

Other mixed anxiety disorders

13.1

307.7

582

230

N05AB03

ATC

perphenazine; systemic, rectal

126.4

307.7

820

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

167.0

307.7

359

N02BE01

ATC

paracetamol; systemic, rectal

2.7

307.7

16589

64733

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

568.2

307.7

550

205

Kela drug reimbursment

Chronic hypertension

+∞

307.7

1420

N06BA12

ATC

lisdexamfetamine; oral

23.5

307.7

498

109

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

8.2

307.7

1081

693

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

9.2

307.7

892

506

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

3.6

307.7

4000

6469

WZC30

NOMESCO Finland

Teaching

3.2

307.7

1890

3176

N05BA01

ATC

diazepam; systemic, rectal

8.5

307.7

2654

1775

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

88.3

307.7

396

E03.89

ICD-10 Finland

Other specified hypothyroidism

42.6

307.7

399

N05AF03

ATC

chlorprothixene; systemic

379.6

307.7

658

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

60.7

307.7

1353

120

A10AE06

ATC

insulin degludec; parenteral

+∞

307.7

423

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

59.3

307.7

2227

212

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

15.8

307.7

1036

347

A10AB04

ATC

insulin lispro; parenteral

92.9

307.7

381

Z3226

NOMESCO Finland

Physiotherapist

2.9

307.7

2540

4793

I25.1

ICD-10 Finland

Atherosclerotic heart disease

79.1

307.7

1030

A10AB05

ATC

insulin aspart; parenteral

124.9

307.7

879

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

+∞

307.7

663

SPAT1222

SPAT

Counselling/guidance promoting independent living

3.6

307.7

1765

2616

F41.8

ICD-10 Finland

Other specified anxiety disorders

8.1

307.7

1185

773

P72

ICPC

Schizophrenia

401.1

307.7

468

R53

ICD-10 Finland

Malaise and fatigue

3.0

307.7

5144

10292

A10AE05

ATC

insulin detemir; parenteral

402.7

307.7

546

N05CF02

ATC

zolpidem; oral

5.7

307.7

3966

4156

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

147.0

307.7

1027

C07AB02

ATC

metoprolol; systemic

5.6

307.7

1623

1556

J45.9

ICD-10 Finland

Asthma, unspecified

2.5

307.7

3022

6735

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

523.2

307.7

606

E66.8

ICD-10 Finland

Other obesity

6.7

307.7

1199

946

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

6.7

307.7

739

573

N03AX16

ATC

[U] pregabalin

5.3

307.7

3983

4511

A10AC01

ATC

insulin (human); parenteral

14.3

307.7

778

283

C07AB07

ATC

bisoprolol; oral

6.6

307.7

5538

5489

I10

ICD-10 Finland

Essential (primary) hypertension

3.1

307.7

6216

12950

IGY99

NOMESCO Finland

Other psychiatric treatment contact

56.9

307.7

846

P76

ICPC

Depressive disorder

32.2

307.7

3001

549

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

2.8

307.7

2266

4423

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

108.6

307.7

809

P06

ICPC

Sleep disturbance

4.3

307.7

3398

4525

R11

ICD-10 Finland

Nausea and vomiting

3.7

307.7

1613

2337

R06.0

ICD-10 Finland

Dyspnoea

3.3

307.7

3889

6789

N06AB10

ATC

escitalopram; oral

43.9

307.7

9293

1953

N06AX12

ATC

bupropion; oral

57.5

307.7

3632

387

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

8.7

307.7

2269

1453

T89

ICPC

Diabetes insulin dependent

187.6

307.7

580

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

7.0

307.7

1414

1084

B01AA03

ATC

warfarin; systemic

26.5

307.7

864

171

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

194.4

307.7

673

N06AA12

ATC

doxepin; systemic

28.0

307.7

782

146

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

374.9

307.7

580

S18

ICPC

Laceration/cut

2.1

307.7

7155

21399

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

231.6

307.7

711

E03

ICD-10 Finland

Other hypothyroidism

36.2

307.7

683

C01DA14

ATC

isosorbide mononitrate; oral

34.3

307.7

539

A10BK03

ATC

empagliflozin; oral

555.5

307.7

948

E11

ICD-10 Finland

Type 2 diabetes mellitus

28.5

307.7

1463

278

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

12.9

307.7

4872

2450

F32.0

ICD-10 Finland

Mild depressive episode

7.4

307.7

792

557

115

Kela drug reimbursment

Breast cancer

+∞

307.7

538

Z76.0

ICD-10 Finland

Issue of repeat prescription

2.7

307.7

5945

13810

A02BC02

ATC

pantoprazole; systemic

3.1

307.7

11831

32350

G44.2

ICD-10 Finland

Tension-type headache

2.7

307.7

2747

5559

P15

ICPC

Chronic alcohol abuse

12.4

307.7

860

364

N03AX12

ATC

[U] gabapentin; oral

5.3

307.7

2803

3022

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

70.6

307.7

822

A06AC01

ATC

ispaghula (psylla seeds); oral

2.8

307.7

3651

7353

T36

ICD-10 Finland

Poisoning by systemic antibiotics

35.1

307.7

1447

223

F99

ICD-10 Finland

Mental disorder, not otherwise specified

45.7

307.7

617

WX892

NOMESCO Finland

Monitored bed care

6.2

307.7

790

664

N06AB08

ATC

fluvoxamine; oral

56.9

307.7

508

N06AX11

ATC

mirtazapine; oral

16.0

307.7

10473

6487

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

135.5

307.7

1859

A10BH01

ATC

sitagliptin; oral

620.9

307.7

715

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

102.0

307.7

667

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

55.2

307.7

493

F41.00

ICD-10 Finland

Moderate panic disorder

137.4

307.7

558

A10BA02

ATC

metformin; oral

24.1

307.7

3125

767

F51.0

ICD-10 Finland

Nonorganic insomnia

4.7

307.7

5249

7072

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

8.6

307.7

1672

1053

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

10.1

307.7

1490

792

N05BA06

ATC

lorazepam; systemic, sublingual

41.4

307.7

844

107

N03AE01

ATC

clonazepam; systemic

12.5

307.7

1124

476

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.8

307.7

3215

6540

103

Kela drug reimbursment

Diabetes, insulin-treated

8001.8

307.7

2758

P01

ICPC

Feeling anxious/nervous/tense

5.8

307.7

5599

6315

N05AH02

ATC

clozapine; systemic

943.8

307.7

563

N05CF01

ATC

zopiclone; oral

7.5

307.7

6259

5734

C03CA01

ATC

furosemide; systemic

11.3

307.7

1895

925

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

109.9

307.7

553

N06AA09

ATC

amitriptyline; systemic

11.9

307.7

1458

658

F39

ICD-10 Finland

Unspecified mood [affective] disorder

32.5

307.7

639

102

F32

ICD-10 Finland

Depressive episode

21.3

307.7

2115

555

N02BF02

ATC

pregabalin; oral

7.8

307.7

1394

962

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

71.2

307.7

389

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

125.3

307.7

1040

N07BB01

ATC

disulfiram; oral

16.6

307.7

1257

404

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

10.8

307.7

4527

2651

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

24.4

307.7

1705

382

Z2446

NOMESCO Finland

Social worker

10.2

307.7

1460

773

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

+∞

307.7

633

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

86.1

307.7

1492

H02AB02

ATC

dexamethasone; systemic

14.1

307.7

871

324

E66.00

ICD-10 Finland

Metabolic syndrome

7.2

307.7

758

545

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

240.9

307.7

2367

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

15.7

307.7

1020

342

Z2445

NOMESCO Finland

Psychologist

15.1

307.7

1209

426

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

24.7

307.7

391

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

+∞

307.7

548

T90

ICPC

Diabetes non-insulin dependent

33.1

307.7

2462

425

N06AX16

ATC

venlafaxine; oral

108.0

307.7

5797

379

F90.0

ICD-10 Finland

Disturbance of activity and attention

14.5

307.7

1882

717

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

2.0

307.7

5382

15550

IGY02, ,

SPAT

35.6

307.7

525

A03FA01

ATC

metoclopramide; systemic, rectal

3.9

307.7

3076

4431

F29

ICD-10 Finland

Unspecified nonorganic psychosis

696.6

307.7

1296

SPAT1240

SPAT

Therapeutic discussion

6.7

307.7

3673

3258

JN3AD

NOMESCO Finland

Abdominal CT examination

3.5

307.7

1699

2612

R4110

NOMESCO Finland

Physiotherapy

2.6

307.7

3779

8228

IGY02

NOMESCO Finland

Psychiatric monitoring contact

49.1

307.7

1272

139

F10.20

ICD-10 Finland

Alcohol dependence currently independent

25.4

307.7

507

103

ZY010

NOMESCO Finland

Hospital outpatient

18.0

307.7

1697

514

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

+∞

307.7

2198

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

61.6

307.7

3695

369

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

16.5

307.7

496

155

XF402

NOMESCO Finland

ECG with work load test

6.8

307.7

780

599

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

14.4

307.7

966

352

TPH04

NOMESCO Finland

Cathetrisation of vein

2.7

307.7

2848

5857

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

9.7

307.7

1058

578

AN1

Coronary angiography

99.9

307.7

428

P99

ICPC

Psychological disorders other

22.4

307.7

1092

259

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

53.8

307.7

337

R02

ICPC

Shortness of breath/dyspnoea

3.2

307.7

1942

3290

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

+∞

307.7

1380

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

69.8

307.7

448

M03BX02

ATC

tizanidine; oral

1.9

307.7

11589

42411

F33

ICD-10 Finland

Recurrent depressive disorder

53.9

307.7

961

SPAT1234

SPAT

Support of social functional capacity

11.6

307.7

638

284

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

+∞

307.7

751

M79.6

ICD-10 Finland

Pain in limb

2.1

307.7

7805

23610

Z01.8

ICD-10 Finland

Other specified special examinations

2.4

307.7

3584

8404

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

7.9

307.7

964

641

F31.8

ICD-10 Finland

Other bipolar affective disorders

191.8

307.7

664

N06AB04

ATC

citalopram; systemic

40.2

307.7

6218

1118

N06AA06

ATC

trimipramine; systemic

28.1

307.7

421

F34.1

ICD-10 Finland

Dysthymia

82.7

307.7

1221

PJA12

NOMESCO Finland

Sentinel node biopsy

32.3

307.7

495

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

4.8

307.7

1316

1452

F40.1

ICD-10 Finland

Social phobias

29.4

307.7

1174

213

H02AB06

ATC

prednisolone; systemic

2.0

307.7

7293

22491

N05AX12

ATC

aripiprazole; systemic

592.4

307.7

1821

B01AF02

ATC

apixaban; oral

17.5

307.7

686

204

A04AA02

ATC

granisetron; systemic, transdermal

79.1

307.7

431

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

95.5

307.7

785

F41.09

ICD-10 Finland

UNS Panic Syndrome

28.1

307.7

1110

210

F43.1

ICD-10 Finland

Post-traumatic stress disorder

11.2

307.7

946

445

N05BE01

ATC

buspirone; oral

67.2

307.7

759

ZXE20

NOMESCO Finland

More than three and less than five hours

4.1

307.7

1463

1897

F32.8

ICD-10 Finland

Other depressive episodes

26.2

307.7

488

N06AB05

ATC

paroxetine; oral

38.8

307.7

1738

246

IBA03

NOMESCO Finland

Psychotherapy evaluation

83.0

307.7

357

R42

ICD-10 Finland

Dizziness and giddiness

2.7

307.7

3156

6618

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

69.0

307.7

690

104

Kela drug reimbursment

Thyroid insufficiency

920.5

307.7

522

N05BA12

ATC

alprazolam; oral

14.8

307.7

2284

866

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

131.8

307.7

854

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

5.2

307.7

1244

1275

WX408

NOMESCO Finland

General anesthesy, balanced

2.4

307.7

3684

8716

A02BC03

ATC

lansoprazole; oral

2.4

307.7

3641

8507

F61.0

ICD-10 Finland

Mixed personality disorders

196.6

307.7

533

Z3231

NOMESCO Finland

Registered nurse

3.3

307.7

4471

7975

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

12.7

307.7

3619

1723

N05AH03

ATC

olanzapine; systemic

206.6

307.7

2261

F10.24

ICD-10 Finland

Alcohol depence active use

28.3

307.7

403

N02AA05

ATC

oxycodone; systemic

6.2

307.7

1618

1406

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

4.5

307.7

1759

2110

XX3DW

NOMESCO Finland

Time consuming IT work

6.0

307.7

907

786

E66.01

ICD-10 Finland

Obesity due to excess calories

4.1

307.7

2039

2718

SPAT1260

SPAT

Consultation of another employee

2.5

307.6

2661

5877

A10AB01

ATC

insulin (human); parenteral

300.1

307.3

410

F33.0

ICD-10 Finland

Recurrent depressive disorder, current episode mild

27.3

305.7

357

SPAT1215

SPAT

Assessment of need for medical rehabilitation

6.4

304.8

709

575

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

77.3

303.4

303

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

3.3

302.5

1521

2463

F33.8

ICD-10 Finland

Other recurrent depressive disorders

124.1

302.3

292

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

19.7

301.9

385

100

R52.2

ICD-10 Finland

Other chronic pain

6.7

300.5

675

524

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

7.1

299.0

642

470

R56.8

ICD-10 Finland

Other and unspecified convulsions

4.5

298.9

973

1123

T82

ICPC

Obesity

5.0

298.8

866

895

N06AA04

ATC

clomipramine; systemic

44.8

297.1

316

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

4.7

296.9

937

1051

C08CA13

ATC

lercanidipine; oral

4.2

296.3

1044

1292

OAA65, ,

SPAT

1.9

296.2

5281

15678

SPAT1254

SPAT

Administration of medicine

2.6

295.5

2291

4783

C09CA06

ATC

candesartan; oral

2.2

295.2

3244

7985

ZXE00

NOMESCO Finland

One hour or less

1.9

294.7

5992

18596

A02BA02

ATC

ranitidine; systemic

2.7

294.6

2019

3945

R4190

NOMESCO Finland

Nutritional therapy

6.5

293.5

669

529

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

13.1

292.6

435

170

N01

ICPC

Headache

2.3

292.5

3106

7529

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

74.7

292.5

293

C09AA02

ATC

enalapril; systemic

3.7

292.4

1222

1734

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.8

292.4

10627

39393

IGP01

NOMESCO Finland

Psychiatric family contact

47.6

292.1

308

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.9

292.0

5900

18261

L03AA13

ATC

pegfilgrastim; parenteral

62.9

290.5

296

A04AA55

ATC

palonosetron, combinations; systemic

110.6

290.0

282

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

20.2

289.9

367

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.0

289.1

4890

14231

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

5.7

289.0

739

669

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.7

288.6

2030

4022

WX002

NOMESCO Finland

Sedation and analgesia

2.6

286.5

2186

4522

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

3.5

285.7

1280

1911

C10AA07

ATC

rosuvastatin; oral

2.1

283.7

3755

9963

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

916.3

283.6

368

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

4.7

281.2

874

966

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.3

281.1

2954

7118

SPAT1263

SPAT

Sampling

1.8

281.1

7198

23958

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

3.0

280.2

1605

2821

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.8

280.1

1884

3639

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

28.8

279.4

322

SPAT1148

SPAT

Treatment of chronic ulcer or burn

3.5

278.9

1239

1838

SPAT1097

SPAT

Recording of ECG

3.3

278.2

1346

2120

IHZ02, ,

SPAT

6.9

275.9

602

450

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

+∞

275.7

352

M03BC51

ATC

orphenadrine, combinations; systemic

2.0

275.7

4435

12647

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

3.2

274.6

1421

2341

P16

ICPC

Acute alcohol abuse

11.9

274.4

427

184

C09CA01

ATC

losartan; oral

2.5

274.2

2264

4870

F60.5

ICD-10 Finland

Anankastic personality disorder

27.6

274.0

319

IBA01, ,

SPAT

6.7

271.4

608

470

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

103.8

271.4

265

D11

ICPC

Diarrhoea

2.3

270.8

2675

6263

M01AE02

ATC

naproxen; oral, rectal

1.7

269.7

10822

40871

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

85.0

269.5

267

SAA01

NOMESCO Finland

Simple examination of mouth

1.9

269.4

15084

62778

ZXD10

NOMESCO Finland

Scheduled procedure

1.9

269.3

4941

14734

H04AA01

ATC

glucagon; nasal, parenteral

452.5

268.8

354

IBA02

NOMESCO Finland

Evaluation of need for psychiatric rehabilitation

110.3

267.3

260

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

50.8

266.9

279

N04BC05

ATC

pramipexole; oral

4.5

266.7

872

1009

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.0

265.3

3876

10650

J01AA02

ATC

doxycycline; systemic

1.7

263.8

12711

50400

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.9

262.0

5271

16184

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

54.8

259.9

269

P27

ICPC

Fear of mental disorder

12.1

259.5

400

169

WZA10, ,

SPAT

7.5

259.3

531

364

IGY99, ,

SPAT

4.9

259.1

764

802

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

69.9

258.9

261

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.7

256.4

9068

32884

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

570.5

255.8

335

L01

ICPC

Neck symptom/complaint

2.1

255.3

3121

7989

D01

ICPC

Abdominal pain/cramps general

2.3

254.1

2569

6065

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

3.5

253.6

1145

1716

E03.80

ICD-10 Finland

Hypothyroidism caused by autoimmune thyroiditis

48.4

252.9

266

R05

ICPC

Cough

1.9

252.8

4402

12853

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.1

252.6

3060

7801

SPAT1216

SPAT

Assessment of functional ability

3.0

252.1

1449

2547

P19

ICPC

Drug abuse

15.4

251.0

349

116

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

13.1

250.6

373

146

M79.1

ICD-10 Finland

Myalgia

2.2

250.2

2883

7198

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.4

250.0

2248

5027

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

2.1

249.9

3273

8605

I20.99

ICD-10 Finland

Angina pectoris, unspecified

64.4

248.9

253

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

18.5

248.4

323

J01FF01

ATC

clindamycin; systemic

2.0

247.4

4039

11519

M25.5

ICD-10 Finland

Pain in joint

1.8

247.3

5900

19048

A29

ICPC

General symptom/complaint other

2.6

246.8

1870

3840

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.9

246.5

4245

12333

K59.09

ICD-10 Finland

Constipation, unspecified

4.6

244.5

769

858

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

60.6

244.3

250

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

6.2

243.5

575

474

L02BA01

ATC

tamoxifen; oral

23.9

241.4

291

PHM76

NOMESCO Finland

Endovenous obliteration of v.saphena magna

+∞

241.1

308

XCK10

NOMESCO Finland

Photography of fundus of eye

4.5

240.8

794

925

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

34.1

240.7

268

M79.0

ICD-10 Finland

Rheumatism, unspecified

8.9

239.9

437

251

G43.9

ICD-10 Finland

Migraine, unspecified

2.8

239.7

1563

2957

K02.1

ICD-10 Finland

Caries of dentine

1.7

239.2

12536

50165

F42.0

ICD-10 Finland

Predominantly obsessional thoughts or ruminations

43.1

237.4

254

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

9.6

237.4

414

221

I49.3

ICD-10 Finland

Ventricular premature depolarization

5.2

236.9

665

664

F41

ICD-10 Finland

Other anxiety disorders

6.8

236.3

522

396

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.2

236.2

2809

7092

R50.9

ICD-10 Finland

Fever, unspecified

2.3

235.9

2368

5561

SPAT1283

SPAT

Restricted health certificate

1.8

235.7

4723

14400

Z51.5

ICD-10 Finland

Palliative care

13.6

235.7

345

130

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

+∞

235.6

301

F40.01

ICD-10 Finland

Agoraphobia with concomitant panic disorder

115.9

235.1

228

N06AA10

ATC

nortriptyline; systemic

12.0

235.0

363

154

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

4.1

234.6

860

1097

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.4

234.0

2092

4658

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.6

233.7

1732

3512

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

4.2

232.6

829

1033

F10.09

ICD-10 Finland

Alcohol intoxication UNS

7.5

232.4

474

323

WX872

NOMESCO Finland

Intensive care

11.9

232.3

361

155

TFP20

NOMESCO Finland

Cardiodefibrillation

518.6

232.3

305

WZC00, ,

SPAT

2.2

232.2

2765

6981

R06AE07

ATC

cetirizine; oral

1.7

231.8

8343

30126

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.7

231.6

10048

38106

R00.2

ICD-10 Finland

Palpitations

3.0

231.4

1357

2411

J01MA02

ATC

ciprofloxacin; systemic

1.8

230.6

5041

15781

S06.0

ICD-10 Finland

Concussion

2.4

230.6

1974

4303

M01AE03

ATC

ketoprofen; systemic, rectal

1.8

228.9

4735

14564

N03AX11

ATC

topiramate; oral

6.3

228.7

535

436

E66.9

ICD-10 Finland

Obesity, unspecified

5.0

228.7

667

692

R74

ICPC

Upper respiratory infection acute

1.7

228.1

8053

28891

F93.89

ICD-10 Finland

Other childhood emotional disorders

309.9

228.0

304

ICB06, ,

NOMESCO Finland

222.5

226.3

306

K78

ICPC

Atrial fibrillation/flutter

37.1

226.2

248

Z08

ICPC

Social welfare problem

23.9

225.5

272

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.9

225.3

3995

11676

ZX120

NOMESCO Finland

Intravenous

3.7

225.0

945

1341

SPAT1252

SPAT

Overall medication plan or its review

5.7

224.9

579

527

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

+∞

224.6

287

SPAT1284

SPAT

Extensive health certificate

5.6

224.4

584

538

A04AA01

ATC

ondansetron; systemic, rectal

4.2

224.4

797

990

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.3

224.1

2208

5136

IBZ06

NOMESCO Finland

Evaluation concerning developmental neuropsychiatry

67.6

223.4

226

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.2

223.1

2386

5752

R07.3

ICD-10 Finland

Other chest pain

2.8

222.8

1441

2710

J01MA12

ATC

levofloxacin; systemic

2.4

222.6

1946

4282

ZXD05

NOMESCO Finland

Urgent procedure

1.8

222.4

4625

14230

F42.9

ICD-10 Finland

Obsessive-compulsive disorder, unspecified

53.1

221.4

230

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.9

220.9

4244

12727

P25

ICPC

Phase of life problem adult

3.3

220.5

1065

1670

F51

ICD-10 Finland

Nonorganic sleep disorders

3.2

219.7

1110

1794

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

12.4

218.9

334

138

A10BD07

ATC

metformin and sitagliptin; systemic

+∞

217.6

278

A11

ICPC

Chest pain NOS

3.4

217.3

1005

1529

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

+∞

216.0

276

P18

ICPC

Medication abuse

106.7

215.4

210

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1391.1

215.2

278

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

12.8

214.8

322

128

201

Kela drug reimbursment

Chronic cardiac insufficiency

39.3

213.7

232

A10AA02, ,

ATC

+∞

213.6

273

K80

ICPC

Cardiac arrhythmia NOS

3.6

213.4

907

1298

R4120

NOMESCO Finland

Occupational therapy

3.7

212.9

886

1248

N05AL01

ATC

sulpiride; systemic

64.5

212.6

216

C08CA02

ATC

felodipine; oral

6.4

212.1

490

393

ICB01, ,

SPAT

22.4

212.0

260

JN3BD

NOMESCO Finland

Extensive abdominal CT

3.1

211.7

1124

1875

SPAT1241

SPAT

Extensive assessment of psychosocial situation

10.1

211.7

358

181

B18.2

ICD-10 Finland

Chronic viral hepatitis C

13.5

211.6

310

117

S29

ICPC

Skin symptom/complaint other

2.0

211.5

3167

8704

UKC02

NOMESCO Finland

Cystoscopy

2.8

211.4

1329

2457

A99

ICPC

Disease/condition unspecnature/site

2.7

211.3

1506

2985

E66

ICD-10 Finland

Obesity

3.2

211.2

1071

1734

C03AA03

ATC

hydrochlorothiazide; oral

7.3

210.7

439

308

R4110, ,

SPAT

2.5

210.3

1671

3504

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

22.9

209.8

256

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

353.8

209.4

278

M01AB05

ATC

diclofenac; systemic, rectal

1.6

209.2

11099

43812

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

+∞

208.9

267

A10AA01, ,

ATC

+∞

208.9

267

E10

ICD-10 Finland

Type 1 diabetes mellitus

466.8

208.9

275

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

30.9

208.8

237

R60.0

ICD-10 Finland

Localized oedema

2.9

207.2

1257

2275

F42.1

ICD-10 Finland

Predominantly compulsive acts [obsessional rituals]

48.2

207.1

218

IEY01

NOMESCO Finland

Psychoeducation, individual

160.1

206.4

284

N17

ICPC

Vertigo/dizziness

2.5

205.2

1682

3581

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

6.5

204.1

468

372

N03AF01

ATC

carbamazepine; oral, rectal

4.8

203.8

614

657

SPAT1153

SPAT

Removal of sutures

1.9

203.6

3680

10780

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

+∞

203.4

260

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

2.2

203.3

2210

5352

N07BA03

ATC

varenicline; oral

3.4

202.9

951

1459

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

10.6

202.9

335

162

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

274.6

201.6

270

F50.9

ICD-10 Finland

Eating disorder, unspecified

12.8

201.5

302

120

R03BB04

ATC

tiotropium bromide; inhalant

3.7

201.0

831

1164

SPAT1238

SPAT

Brief therapy

6.6

200.7

453

353

S97

ICPC

Chronic ulcer skin

5.9

200.4

494

428

R01AD09

ATC

mometasone; nasal

1.6

199.5

8651

32354

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

8.5

198.5

373

225

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

67.7

197.8

200

IER01

NOMESCO Finland

Psychoeducation, group

269.5

197.7

265

EBA15

NOMESCO Finland

Extraction of multiple teeth

6.4

197.5

458

369

SFA10

NOMESCO Finland

One-surface restoration

1.6

197.3

11092

44120

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

3.6

196.7

841

1208

WF002

NOMESCO Finland

Radical radiotherapy

21.1

196.4

245

C02AC05

ATC

moxonidine; oral

17.4

195.9

260

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

+∞

195.6

250

HAC20

NOMESCO Finland

Total mastectomy

35.4

195.4

216

J02AC01

ATC

fluconazole; systemic

1.6

195.0

6534

22866

IEV99

NOMESCO Finland

Other psychiatric network intervention

435.8

194.8

257

IBB02

NOMESCO Finland

Psychiatric evaluation of working capacity and rehabilitation

1257.1

194.8

252

EBA00

NOMESCO Finland

Extraction of tooth

1.6

194.8

7145

25588

CL2S4, ,

SPAT

66.7

194.5

197

M04AA01

ATC

allopurinol; systemic

3.9

193.7

736

965

F84.5

ICD-10 Finland

Asperger syndrome

17.8

193.6

255

N06AX18

ATC

reboxetine; oral

66.0

192.3

195

L02

ICPC

Back symptom/complaint

2.2

192.0

2105

5109

A10BB12

ATC

glimepiride; oral

638.5

192.0

251

WX780

NOMESCO Finland

Remote monitoring CPAP

4.0

191.9

718

930

A10BH05

ATC

linagliptin; oral

1236.5

191.7

248

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

+∞

191.7

245

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

50.8

191.4

200

F60.8

ICD-10 Finland

Other specific personality disorders

65.6

191.2

194

BAA60

NOMESCO Finland

Total thyroidectomy

86.7

190.0

188

N05AF01

ATC

flupentixol; systemic

46.4

190.0

201

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

4.2

188.8

654

794

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

+∞

188.5

241

L12

ICPC

Hand/finger symptom/complaint

1.9

188.4

3153

8977

TPX10

NOMESCO Finland

Implantation of vascular injection port

13.2

188.1

278

107

SPAT1312

SPAT

General health counselling

1.7

187.6

5778

19736

ZXA00

NOMESCO Finland

Right side

2.0

187.5

2639

7065

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

5.3

186.2

504

484

IFA99

NOMESCO Finland

Other psychiatric pharmacotherapy service

617.9

185.8

243

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

3.4

185.7

847

1274

J01DA01

ATC

[U] cefalexin

1.6

185.5

10315

40661

N17.9

ICD-10 Finland

Acute renal failure, unspecified

11.7

185.5

290

126

ZXY01

NOMESCO Finland

Chief Physician, Head of Department or Deputy Chief Physician

57.0

185.4

191

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.4

184.7

1661

3690

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

184.6

236

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.6

184.6

1409

2889

C07AG02

ATC

carvedilol; oral

12.0

184.3

285

121

E0000UV, ,

ATC

1.6

184.0

7271

26422

K08.3

ICD-10 Finland

Retained dental root

3.1

182.0

998

1696

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

53.3

182.0

189

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

71.4

181.9

183

SPAT1389

SPAT

Visit based on need for special support

3.6

181.5

782

1129

OAB42, ,

SPAT

2.1

181.3

2330

6022

A46

ICD-10 Finland

Erysipelas

2.5

181.2

1450

3044

E87.6

ICD-10 Finland

Hypokalaemia

9.9

180.9

309

159

C61

ICD-10 Finland

Malignant neoplasm of prostate

13.3

180.3

266

102

Z72.2

ICD-10 Finland

Drug use

25.8

180.1

213

Z02.7

ICD-10 Finland

Issue of medical certificate

2.7

180.1

1256

2455

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.7

179.6

1244

2422

I20.09

ICD-10 Finland

Unstable angina

157.8

179.2

247

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.8

178.9

1155

2163

PHD76

NOMESCO Finland

Resection of long saphenous vein

594.8

178.7

234

XKD00

NOMESCO Finland

Uroflowmetry

2.8

178.5

1115

2049

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

4.7

178.3

548

597

XF600

NOMESCO Finland

Bloodpressure measurement

3.8

177.7

705

956

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

156.5

177.7

245

OAB38, ,

SPAT

3.5

177.6

779

1139

R52.9

ICD-10 Finland

Pain, unspecified

2.4

177.4

1629

3651

P81

ICPC

Hyperkinetic disorder

9.0

177.2

320

181

X78

ICD-10 Finland

Intentional self-harm by sharp object

27.5

177.0

206

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1138.8

176.8

229

WX723

NOMESCO Finland

CPAP therapy

3.8

176.8

698

943

TFP34

NOMESCO Finland

Electrophysiological investigation

202.9

176.7

240

HA1AA

NOMESCO Finland

X-ray mammography

4.4

175.9

589

694

R96

ICPC

Asthma

2.5

175.3

1427

3019

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

4.2

175.3

609

741

SFA20

NOMESCO Finland

Two-surface restoration

1.6

175.2

11591

47268

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.8

174.8

1144

2158

SPAT1281

SPAT

Other administrative function

2.7

174.4

1172

2244

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

3.8

174.3

695

946

R55

ICD-10 Finland

Syncope and collapse

2.7

174.2

1168

2233

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

17.8

173.3

228

K85

ICPC

Elevated blood pressure

2.4

173.0

1456

3131

HAB40

NOMESCO Finland

Wedge excision of mammary gland

13.5

172.1

252

IAA01, ,

SPAT

11.5

171.7

271

120

SPAT1229

SPAT

Assessment of need for aid

4.4

171.1

563

653

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

18.0

170.0

223

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

21.1

170.0

212

IAB01, ,

SPAT

55.4

169.3

175

T74.1

ICD-10 Finland

Physical abuse

4.7

168.0

518

566

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.4

167.7

1519

3380

M01AH05

ATC

etoricoxib; oral

1.5

167.0

10778

43492

Z3229

NOMESCO Finland

Other healthcare associate professional

3.0

167.0

925

1581

F43.0

ICD-10 Finland

Acute stress reaction

2.4

166.4

1425

3088

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

9.9

166.3

284

146

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

1067.0

165.9

215

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

+∞

165.8

212

J01FA06

ATC

roxithromycin; oral

1.6

165.7

5648

19669

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.9

165.6

981

1746

ZXY82

NOMESCO Finland

Nurse in multidisciplinary team

83.1

165.2

164

F41.01

ICD-10 Finland

Severe panic disorder

190.0

165.1

225

G04BD12

ATC

mirabegron; oral

2.9

163.9

961

1700

K59.1

ICD-10 Finland

Functional diarrhoea

3.3

163.8

803

1268

S10

ICPC

Boil/carbuncle

2.9

163.7

974

1738

A10BJ05

ATC

dulaglutide; parenteral

+∞

163.4

209

P28

ICPC

Limited function/disability (P)

29.6

163.4

187

X59

ICD-10 Finland

Exposure to unspecified factor

1.8

163.3

3256

9768

M70.6

ICD-10 Finland

Trochanteric bursitis

2.4

162.9

1385

2990

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

2.8

162.5

1030

1907

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

10.6

162.4

267

128

ZXE30

NOMESCO Finland

More than five and less than seven hours

5.6

162.4

418

380

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3020891) Body temperature

799

704

5.90

320.37

4.9

2.5

36.94

°c

0.04

793

698

(3023183) Ammonium ion [Moles/volume] in Plasma

522

252

10.66

316.86

3.0

2.7

35.05

34.39

umol/l

0.10

487

229

(3020630) Protein [Mass/volume] in Serum or Plasma

1133

1442

4.13

311.29

2.1

1.3

67.45

68.74

g/l

5.71

1069

1353

(44816559) Phosphatidylethanol [Mass/volume] in Blood

2166

1486

8.10

307.65

2.0

1.5

0.30

0.28

mg/l

0.57

1065

728

(3026782) Osmolality of Urine

3613

7278

2.83

307.65

2.7

1.9

528.92

576.14

mosm/kgh2o

19.37

3160

6283

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

8519

16562

3.77

307.65

2.0

1.4

97.47

98.85

pmol/l

1.65

4750

8716

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

4428

11811

2.14

307.65

2.4

1.5

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

17492

67689

3.44

307.65

13.0

4.4

95.52

93.01

ml/min/173m2

49.86

15971

58607

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1384

1334

5.53

307.65

8.6

4.8

24.78

24.85

mmol/l

0.25

1370

1329

(3004119) Hemoglobin [Mass/volume] in Venous blood

1055

1096

5.05

307.65

3.6

1.7

134.49

141.94

g/l

16.38

1026

1073

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

3271

7085

2.58

307.65

2.7

1.9

1.02

0.85

e6/l

1.41

1591

3408

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2561

3609

3.94

307.65

2.2

1.5

29.24

28.48

8.64

2485

3502

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

19132

83566

4.74

307.65

12.1

5.4

28.88

26.13

u/l

55.18

18789

81351

(3019977) pH of Arterial blood

1881

1661

6.18

307.65

9.0

4.6

7.41

7.42

3.21

1026

915

(3044889) 12 lead EKG panel

12823

35818

3.24

307.65

3.5

1.8

6313.94

0.43

0.48

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

6413

12903

3.21

307.65

3.2

1.4

77.59

11.83

ng/l

1.17

3309

4225

(3035350) Ketones [Presence] in Urine by Test strip

10363

35289

1.99

307.65

3.7

2.5

4.75

1.98

estimate

0.82

2243

6266

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2862

4655

3.44

307.65

1.9

1.3

—

(3012516) Albumin [Mass/volume] in Urine

4660

6232

4.60

307.65

3.6

1.8

53.29

68.29

mg/l

2.05

3060

3245

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1965

2164

4.95

307.65

2.5

2.4

0.23

g/l

2.44

1835

2060

(4198724) Urine methamphetamine measurement

435

23.26

307.65

2.9

3.5

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

5435

9604

3.54

307.65

2.4

1.8

2.62

2.32

mg/l

20.24

4745

8289

(3028707) Methadone [Presence] in Urine by Screen method

1781

513

19.06

307.65

3.4

1.8

—

(3019198) Lymphocytes [#/volume] in Blood

11002

30320

2.84

307.65

7.1

4.9

2.01

1.97

e9/l

4.26

9901

27658

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

14412

46494

3.01

307.65

4.2

3.1

8.85

7.14

mm/h

62.51

13649

44152

(3002582) Erythrocytes [#/volume] in Urine

6091

14004

2.71

307.65

3.2

2.1

64.32

63.18

e6/l

0.02

4562

9961

(3037467) Urinalysis macro (dipstick) panel - Urine

12872

44697

2.26

307.65

4.4

3.0

2.01

2.46

0.26

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

15057

57096

2.33

307.65

4.1

2.2

43.37

30.56

u/l

79.93

14454

55271

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

3553

3540

5.92

307.65

2.9

1.3

705.05

176.97

ng/l

11.46

2761

2536

(3020682) Albumin/Creatinine [Ratio] in Urine

4691

6291

4.59

307.65

4.3

2.0

9.11

11.06

mg/mmol

1.17

3034

3294

(3027945) Reticulocytes/Erythrocytes in Blood

1713

2165

4.26

307.65

2.9

1.9

1.76

1.41

30.47

1543

1950

(3027008) Opiates [Presence] in Urine

2824

6003

2.59

307.65

2.8

1.3

—

(3009508) Creatinine [Moles/volume] in Urine

6549

9426

4.71

307.65

3.8

1.8

8.48

9.16

mmol/l

11.24

5765

8524

(3000991) Gas panel - Venous blood

1626

1617

5.41

307.65

9.8

4.5

—

(3009261) Glucose [Presence] in Urine by Test strip

10383

35560

1.98

307.65

3.7

2.5

0.15

0.00

estimate

0.57

2169

6230

(3002032) Base excess in Venous blood by calculation

1780

1921

5.02

307.65

4.5

2.2

1.69

1.96

mmol/l

2.06

1553

1699

(3007853) Bacteria identified in Skin by Aerobe culture

2609

5394

2.65

307.65

1.9

1.4

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

8272

15400

3.91

307.65

4.9

3.1

37.31

38.39

g/l

49.11

7793

14490

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1781

2242

4.29

307.65

4.0

2.0

220.93

216.46

u/l

0.78

1696

2129

(3006504) Eosinophils/Leukocytes in Blood

9773

26437

2.68

307.65

7.1

5.1

2.78

2.91

6.14

9235

25082

(3021960) Folate [Moles/volume] in Serum or Plasma

5472

8304

4.19

307.65

1.7

1.3

19.33

20.51

nmol/l

5.78

4881

7204

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1091

1057

5.43

307.65

2.1

1.2

6.00

3.17

ug/l

4.93

964

919

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

10022

21063

3.80

307.65

6.1

2.5

10.17

11.19

umol/l

10.83

9454

19763

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

6543

16596

2.46

307.65

1.4

1.2

1.67

1.91

u/ml

0.61

1866

5125

(3021601) Nitrite [Presence] in Urine by Test strip

10258

34873

1.99

307.65

3.7

2.5

0.00

estimate

0.91

2248

6285

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

4105

6566

3.70

307.65

1.7

1.4

32366495.48

50288855.47

pmol/l

0.89

3584

5894

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2987

6602

2.50

307.65

2.9

1.9

3.13

3.19

e6/l

0.10

1306

2921

(3030467) Casts [#/volume] in Urine by Automated count

5309

11670

2.75

307.65

3.1

2.0

0.29

0.24

e6/l

0.88

3803

7765

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

8289

12882

4.82

307.65

6.3

2.8

1.21

1.22

mmol/l

10.77

7752

11787

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

18359

75822

3.74

307.65

15.1

5.7

19.76

21.70

mg/l

12.04

15143

54930

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1827

1957

5.06

307.65

4.5

2.2

5.89

5.90

kpa

0.17

1773

1913

(3022096) Basophils/Leukocytes in Blood

9756

26413

2.68

307.65

7.2

5.1

0.68

0.69

1.63

9201

25001

(3003458) Phosphate [Moles/volume] in Serum or Plasma

2503

2603

5.38

307.65

6.2

3.5

1.05

1.03

mmol/l

1.38

2351

2322

(3023368) Bacteria identified in Blood by Culture

4588

7957

3.47

307.65

4.6

2.2

—

(3024354) Oxygen [Partial pressure] in Venous blood

1558

1715

4.87

307.65

3.9

2.1

4.88

4.72

kpa

1.23

1512

1679

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

5191

8667

3.72

307.65

2.2

1.4

1.49

1.18

148.29

4679

8039

(3003396) Base excess in Arterial blood by calculation

1855

1634

6.19

307.65

8.8

4.6

0.85

0.68

mmol/l

0.70

1533

1232

(3018418) pH of Serum or Plasma

5634

7972

4.56

307.65

3.9

2.0

7.40

7.39

0.48

3929

5184

(3028300) Cannabinoids [Presence] in Urine

2834

6025

2.59

307.65

2.9

1.3

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

8433

27452

1.94

307.65

2.8

2.2

—

estimate

—

(3011288) Drugs identified in Urine by Screen method Nominal

2391

2841

4.67

307.65

3.9

1.4

—

(3013115) Eosinophils [#/volume] in Blood

11045

30488

2.84

307.65

7.5

5.0

0.19

e9/l

1.07

9874

27532

(3048689) Calprotectin [Mass/mass] in Stool

3917

9915

2.23

307.65

2.6

3.1

104.23

114.21

ug/g

0.98

3099

8122

(3013650) Neutrophils [#/volume] in Blood by Automated count

11753

31832

3.08

307.65

10.9

5.0

4.06

3.87

e9/l

14.19

10334

27932

(3015377) Calcium [Moles/volume] in Serum or Plasma

6739

11287

4.02

307.65

2.9

1.5

2.35

mmol/l

0.07

6280

10371

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

9244

15309

4.79

307.65

6.8

2.9

1.21

1.22

mmol/l

26.46

8048

13342

(3012095) Magnesium [Moles/volume] in Serum or Plasma

3144

3368

5.38

307.65

3.6

1.8

0.82

0.86

mmol/l

27.55

2986

3158

(3044640) Blood type and Crossmatch panel - Blood

5825

16574

2.08

307.65

2.4

1.5

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

3412

5507

3.55

307.65

2.3

1.5

2.42

2.39

mmol/l

16.17

3045

4889

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

896

800

5.85

307.65

2.7

1.4

95.97

33.08

ng/l

9.03

765

691

(3019060) Gas panel - Arterial blood

911

744

6.40

307.65

5.1

3.1

—

(40758558) Short blood count panel - Blood

5988

14760

2.49

307.65

6.8

3.4

—

(3016879) Cocaine [Presence] in Urine

2715

5321

2.81

307.65

3.0

1.3

—

(3019069) Monocytes/Leukocytes in Blood

9785

26476

2.68

307.65

7.2

5.1

8.39

8.45

1.43

9250

25160

(3009343) pH of Capillary blood

1267

1400

4.79

307.65

3.3

2.5

7.41

1.45

1068

1092

(3007164) IgA [Mass/volume] in Serum or Plasma

5662

14034

2.44

307.65

1.5

1.3

2.21

2.13

g/l

3.01

3677

9844

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1789

2952

3.25

307.65

3.3

1.7

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1474

1641

4.80

307.65

3.8

1.7

1.23

mmol/l

0.86

1251

1361

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

14565

40406

4.01

307.65

7.9

4.1

75.43

71.35

u/l

25.99

13904

38146

(3023520) Reticulocytes [#/volume] in Blood

1244

1297

5.07

307.65

2.8

1.8

73.91

64.65

e9/l

9.88

882

927

(3026008) Bacteria identified in Urine by Culture

5016

12645

2.33

307.65

2.7

1.8

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1750

1935

4.89

307.65

3.3

2.9

4.57

4.84

pmol/l

14.05

1574

1788

(3018010) Neutrophils/Leukocytes in Blood

9951

27700

2.61

307.65

6.9

4.9

56.09

55.08

15.02

9571

26741

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

603

112

27.87

307.65

2.5

3.3

—

(3020779) Urea [Moles/volume] in Serum or Plasma

1514

1381

5.88

307.65

8.3

3.2

7.32

5.94

mmol/l

13.10

1462

1317

(3032080) INR in Blood by Coagulation assay

7225

13117

3.77

307.65

8.7

2.0

1.10

1.02

inr

52.46

6019

10475

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

5691

9286

3.91

307.65

2.4

1.6

236.84

209.58

u/l

0.46

5447

8860

(3037522) Nuclear Ab [Titer] in Serum

3542

8083

2.46

307.65

1.4

1.3

437.46

549.22

titre

2.58

613

1514

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2036

2856

3.88

307.65

1.9

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

2152

4039

2.88

307.65

1.3

1.2

133.40

97.89

u/ml

2.69

800

1485

(3019225) pH of Specimen

1613

2586

3.32

307.65

3.5

2.0

7.35

7.32

2.90

1200

1572

(3021589) Normoblasts [#/volume] in Blood

9192

26643

2.36

307.65

11.1

5.9

0.00

e9/l

2.36

7497

22107

(3018095) Leukocytes [#/volume] in Urine

7167

19058

2.39

307.65

3.9

2.5

59.34

63.82

e6/l

0.21

4875

11569

(3015736) pH of Urine

8771

26861

2.14

307.65

3.3

2.3

6.22

6.19

1.80

5070

15662

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

2156

3841

3.04

307.65

2.8

1.8

59.77

50.09

u/l

0.16

1819

3315

(3020564) Creatinine [Moles/volume] in Serum or Plasma

19166

82341

5.40

307.65

17.2

5.6

72.04

71.74

umol/l

0.91

19006

81109

(3042936) Bacteria identified in Isolate by Culture

2700

5388

2.76

307.65

2.2

1.5

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

18446

67665

5.96

307.65

15.5

4.2

139.61

139.82

mmol/l

30.73

18107

65518

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

9605

24838

2.82

307.65

2.6

2.0

70.74

75.19

nmol/l

39.30

9009

23621

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2097

2961

3.86

307.65

1.8

1.2

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

930

792

6.14

307.65

11.3

5.3

16.42

16.98

3.78

896

750

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1592

1293

6.64

307.65

9.8

5.2

125.78

128.14

g/l

2.46

1558

1252

(3001604) Monocytes [#/volume] in Blood

10734

29109

2.85

307.65

7.1

5.0

0.56

0.53

e9/l

24.89

9441

26013

(3013512) EKG study

5440

10279

3.28

307.65

2.9

1.6

0.73

0.01

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

8123

17061

3.35

307.65

3.6

2.2

33.73

28.62

u/l

1.59

7703

16381

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

2528

4510

3.08

307.65

2.7

1.8

6.71

6.33

umol/l

0.36

2128

3935

(3009466) Valproate [Moles/volume] in Serum or Plasma

662

207

16.59

307.65

6.4

3.2

373.67

399.70

umol/l

1.45

586

175

(3023103) Potassium [Moles/volume] in Serum or Plasma

18486

68022

6.03

307.65

15.6

4.2

3.92

3.93

mmol/l

2.38

18108

65591

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1298

1438

4.78

307.65

3.3

2.4

5.18

5.13

kpa

1.35

1260

1379

(3002030) Lymphocytes/Leukocytes in Blood

10100

28147

2.63

307.65

7.0

4.9

29.63

31.05

33.98

9646

27027

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

17364

66612

3.40

307.65

4.6

2.5

5.77

5.35

mmol/l

277.34

16407

63016

(3000764) Benzodiazepines [Presence] in Urine

2822

5924

2.62

307.65

2.9

1.3

—

(3027944) Amphetamines [Presence] in Urine

2759

6012

2.52

307.65

2.8

1.3

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1892

1650

6.26

307.65

8.8

4.6

5.14

4.97

kpa

7.40

1827

1577

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

4766

10240

2.76

307.65

1.9

1.4

0.88

0.80

mg/l

1.06

3436

7432

(3006315) Basophils [#/volume] in Blood

10751

29116

2.86

307.65

7.1

5.0

0.04

e9/l

3.39

9447

26013

(3013826) Glucose [Moles/volume] in Serum or Plasma

10924

25962

3.47

307.65

5.3

2.4

6.40

5.85

mmol/l

120.86

10254

22601

(3022948) Iron [Moles/volume] in Serum or Plasma

3373

4681

4.16

307.65

2.5

1.6

14.73

21.22

umol/l

0.88

3137

4420

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1213

1571

4.07

307.65

3.8

2.6

76.07

65.69

ng/l

2.58

1095

1441

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

16657

50408

5.02

307.65

4.9

2.2

14.37

14.16

pmol/l

23.56

15681

46618

(3001122) Ferritin [Mass/volume] in Serum or Plasma

11478

35178

2.51

307.65

3.5

2.5

89.98

72.12

ug/l

19.96

10935

33837

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1127

1195

4.96

307.65

3.3

2.6

1.42

1.16

mmol/l

1.31

838

830

(3014111) Lactate [Moles/volume] in Serum or Plasma

1688

1666

5.47

307.65

8.3

3.9

1.35

1.30

mmol/l

0.72

1651

1633

(3008152) Bicarbonate [Moles/volume] in Arterial blood

992

877

5.93

307.65

7.3

4.0

24.50

24.30

mmol/l

0.64

953

827

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

18203

63976

5.95

307.65

6.1

2.5

1.74

mu/l

0.05

17487

60354

(40768797) Stomach Pathology biopsy report

2839

5578

2.82

307.65

1.2

1.1

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

2703

2770

5.52

307.65

2.1

1.6

374.22

384.48

nmol/l

1.40

2510

2617

(3019309) Folate [Moles/volume] in Red Blood Cells

2998

3071

5.60

307.65

1.7

1.5

1162.70

1140.45

nmol/l

0.48

2347

2289

(3016502) Oxygen saturation in Arterial blood

1683

1352

6.74

307.65

9.2

5.0

95.84

96.43

1.71

1632

1296

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2809

3504

4.53

307.65

2.5

1.6

23.92

27.53

22.69

2604

3267

(3000850) Epithelial cells [#/volume] in Urine

4198

8854

2.75

307.65

2.6

1.8

6.67

6.42

e6/l

0.40

3809

7844

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

3255

5006

3.71

307.65

3.5

1.5

223.32

37.03

ng/l

7.66

1908

2166

(36304419) Bacteria [Presence] in Urine

5180

11614

2.68

307.65

3.0

2.0

1.84

0.45

estimate

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

976

811

6.31

307.65

11.1

5.9

24.21

mmol/l

0.01

960

797

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

6621

13957

3.07

307.65

3.0

1.7

55.47

58.95

u/l

3.05

6113

13061

(3027801) Oxygen [Partial pressure] in Arterial blood

1891

1649

6.26

307.65

8.8

4.6

12.57

14.37

kpa

17.03

1827

1578

(3031040) Bacteria [#/volume] in Urine by Automated count

12235

40400

2.35

307.65

4.5

2.9

1197.63

1361.30

e6/l

0.10

142

418

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

16627

64976

2.72

307.65

5.5

2.4

37.54

35.22

mmol/mol

213.53

15877

62402

(3004789) Transferrin [Mass/volume] in Serum or Plasma

3123

4024

4.44

307.65

2.4

1.6

2.46

2.52

g/l

6.04

2881

3742

(3033658) Prothrombin time (PT) actual/Normal

4898

9985

2.94

307.65

4.3

2.2

95.36

96.54

2.67

4778

9723

(3005719) IgG [Mass/volume] in Serum or Plasma

1910

3341

3.07

307.65

2.5

2.3

10.27

10.93

g/l

11.16

1770

3109

(3012544) pH of Venous blood

1838

1975

5.05

307.65

4.4

2.1

7.37

0.03

1029

1082

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

457

179

13.11

307.12

3.1

2.4

0.95

0.83

nmol/l

0.98

385

165

(3019150) Specific gravity of Urine by Refractometry

5121

14882

1.98

306.90

3.6

2.4

1.32

1.35

kg/l

0.03

3277

9034

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

2018

3860

2.81

306.41

5.4

2.4

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

982

1129

4.55

303.04

1.7

1.2

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

381

19.70

298.67

3.9

2.1

0.33

0.29

iu/ml

0.49

197

(3026493) Urate [Moles/volume] in Serum or Plasma

4453

12405

2.04

298.15

2.3

1.6

328.59

319.01

umol/l

8.19

4026

11556

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

16219

68450

2.02

296.65

18.6

6.4

13.34

13.11

113.51

16020

67170

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

718

612

6.08

296.05

2.4

1.9

390.82

432.24

ug/l

0.14

673

555

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1354

2070

3.45

292.51

1.8

1.5

—

(3029937) Albumin [Presence] in Urine by Test strip

5636

17193

1.90

291.12

3.8

2.5

0.00

estimate

0.40

2137

6008

(4035726) Immunohistochemistry procedure

1130

1517

3.91

290.40

1.4

1.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1126

1514

3.90

288.77

4.0

2.0

17.04

13.27

ug/l

0.16

861

999

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

4287

11945

2.02

285.18

1.4

1.3

20.75

29.31

iu/ml

1.98

1159

3625

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

7830

26736

1.78

280.88

1.9

1.5

1.53

1.27

mmol/l

71.28

6843

24253

(3028026) IgM [Mass/volume] in Serum or Plasma

1483

2498

3.14

276.96

1.8

1.7

1.23

1.26

g/l

0.27

1394

2358

(3017143) Hepatitis C virus Ab [Presence] in Serum

4032

11100

2.03

275.84

1.8

1.6

—

(1616796) Gas panel - Central venous blood

536

350

7.88

270.85

3.1

2.0

—

(3018405) Lactate [Moles/volume] in Arterial blood

561

396

7.30

268.28

4.0

2.7

1.42

1.38

mmol/l

0.26

556

390

(3011397) Hemoglobin [Presence] in Urine by Test strip

4697

13855

1.92

263.40

3.5

2.6

0.32

0.19

0.31

103

(3017181) Myelocytes/Leukocytes in Blood

1817

3573

2.71

260.71

4.9

4.1

0.84

0.43

6.51

496

559

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

778

827

4.88

260.49

4.0

2.0

52.95

47.59

4.36

764

818

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

3894

10832

2.00

256.83

1.3

5.97

10.47

u/ml

5.79

1552

4826

(3002179) Metamyelocytes/Leukocytes in Blood

1754

3425

2.73

254.68

4.6

3.9

0.60

0.43

1.15

473

569

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

7945

27808

1.72

254.37

3.5

2.3

0.09

0.04

estimate

0.42

1906

5173

(36660697) Celiac disease serology panel - Serum

2359

5355

2.38

254.37

1.2

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

330

18.52

253.72

2.3

2.1

143.87

86.14

ug/min

0.50

216

(3004588) Protein electrophoresis panel - Serum or Plasma

869

1049

4.31

253.27

1.8

1.3

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

17614

77943

2.17

249.11

5.0

3.1

2.81

3.01

mmol/l

169.46

16826

74989

(3017732) Neutrophils [#/volume] in Blood

2729

6696

2.21

246.54

3.5

1.9

4.52

4.17

e9/l

1.12

2432

6007

(3021440) Promyelocytes/Leukocytes in Blood

1744

3505

2.64

239.51

4.9

4.2

0.09

0.02

4.39

422

492

(3012501) Base excess in Blood by calculation

500

354

7.26

238.46

3.7

1.9

2.17

1.68

mmol/l

3.02

314

204

(3025159) Blasts/Leukocytes in Blood

1778

3618

2.61

238.45

5.2

4.3

0.05

0.01

2.08

393

503

(3024928) Oxygen saturation in Venous blood

524

426

6.32

224.40

3.8

1.7

63.98

62.70

0.44

510

420

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

17492

77843

2.06

224.17

4.7

3.0

4.67

4.93

mmol/l

238.02

16783

75237

(3000570) Elastase.pancreatic [Mass/mass] in Stool

660

695

4.90

222.83

1.4

1.2

300.71

360.23

ug/g

5.43

336

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

549

477

5.92

222.24

2.0

1.5

1.49

ug/l

0.00

499

411

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

16478

71912

1.87

221.51

3.9

2.7

1.38

1.16

mmol/l

191.44

15652

69252

(40767503) Oxygen content in Capillary blood by calculation

461

329

7.19

218.50

2.4

1.4

17.27

18.59

11.46

452

324

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

17408

77542

2.01

216.39

4.6

3.0

1.39

1.51

mmol/l

261.21

16624

74777

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

425

278

7.83

214.32

1.1

18947.92

9.39

iu/ml

0.50

117

(3021387) Prolactin [Units/volume] in Serum or Plasma

1828

3995

2.43

211.58

1.7

1.5

319.07

264.71

mu/l

5.57

1654

3674

(3027273) Bicarbonate [Moles/volume] in Venous blood

664

739

4.64

211.45

3.7

2.0

25.16

25.54

mmol/l

1.74

641

701

(3036489) Thrombin time

845

1157

3.79

210.72

2.2

1.6

20.44

19.82

2.36

730

967

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

269

+∞

210.48

2.3

0.0

146.29

—

nmol/l

—

236

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

660

737

4.62

209.41

5.9

2.5

1.86

1.58

4.11

619

691

(3017446) Testosterone [Moles/volume] in Serum or Plasma

2589

6616

2.11

209.35

2.8

1.9

12.97

14.68

nmol/l

18.84

2371

6359

(3021901) Oxygen saturation in Capillary blood

406

262

7.93

206.62

2.6

2.1

91.36

92.82

2.50

399

256

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

643

713

4.65

205.53

2.0

1.8

1.44

1.08

g/l

14.13

568

620

(3020191) Ethanol [Moles/volume] in Serum or Plasma

413

283

7.47

201.57

1.6

1.2

1.42

1.55

promille

0.55

315

229

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

715

898

4.11

198.41

3.5

2.7

24.67

24.61

mmol/l

0.20

681

855

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1409

2796

2.65

196.85

1.2

1.1

3.20

7.63

u/ml

0.51

(3003181) Sodium [Moles/volume] in Urine

316

146

11.04

196.02

1.6

1.4

63.83

76.91

mmol/l

1.71

254

121

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

255

17.53

192.65

3.0

1.4

157.01

105.66

umol/l

0.67

125

(3022145) Colonoscopy Study observation

2260

5674

2.13

189.79

1.4

1.5

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

1409

2853

2.59

189.23

1.5

1.4

7.93

7.68

u/l

0.32

1122

2359

(3028626) Oxygen [Partial pressure] in Capillary blood

563

598

4.84

188.20

3.3

8.85

9.41

kpa

7.17

550

580

(3007930) Methemoglobin/Hemoglobin.total in Blood

594

669

4.57

186.59

6.3

2.7

0.86

0.93

2.44

558

628

(3008295) Osmolality of Serum or Plasma

300

138

11.08

186.51

1.7

1.4

283.64

285.45

mosm/kgh2o

0.45

235

111

(3007461) Platelets [#/volume] in Blood

19592

92991

4.42

184.68

24.2

8.2

262.98

255.94

e9/l

47.12

19360

90852

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

731

994

3.80

183.66

2.3

1.7

96.48

93.58

2.05

702

935

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

5357

18073

1.67

180.90

2.6

2.1

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1004

1724

3.03

180.08

1.5

—

(3035941) MCH [Entitic mass]

19595

93124

4.37

179.87

24.0

8.1

30.15

30.09

4.27

19477

92173

(3024731) MCV [Entitic mean volume] in Red Blood Cells

19594

93117

4.37

179.82

24.0

8.1

90.07

89.71

25.17

19476

92156

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

19596

93137

4.38

179.65

24.5

8.2

41.22

43.19

10.89

19473

92077

(3026361) Erythrocytes [#/volume] in Blood

19595

93157

4.35

178.42

24.1

8.2

4.61

4.65

e12/l

25.96

19334

90811

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

221

21.59

178.34

4.4

1.2

26.75

14.65

u/ml

1.71

213

(3010813) Leukocytes [#/volume] in Blood

19595

93202

4.32

176.43

24.2

8.2

6.79

6.42

e9/l

128.37

19326

90834

(3000963) Hemoglobin [Mass/volume] in Blood

19597

93234

4.33

175.74

24.3

8.2

138.12

139.55

g/l

39.45

19480

92288

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

5724

19798

1.64

174.41

2.7

2.1

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

757

1116

3.50

170.55

1.4

1.2

448.75

426.39

mg/l

0.65

714

1072

(3000494) Fungus identified in Specimen by Culture

2513

6882

1.96

166.21

1.5

1.3

—

(40761536) Microorganisms panel - Urine sediment

1860

4559

2.16

164.43

3.7

2.3

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

678

978

3.57

157.30

2.6

2.1

173.80

159.32

3.11

647

907

(46235355) HIV 1 and 2 tests - Meaningful Use set

7006

25964

1.55

155.89

2.4

2.1

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

258

128

10.25

154.10

6.4

4.3

10.42

9.16

mg/l

2.14

241

116

(3041096) Erythrocytes [Presence] in Urine by Automated

6009

21543

1.58

153.94

3.0

2.1

0.19

0.08

estimate

0.33

1884

5075

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

673

991

3.50

151.72

1.5

1.2

7309.17

578.89

e6/l

0.61

515

785

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1026

1970

2.71

151.42

1.3

1.2

1.06

0.74

u/ml

0.32

112

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

664

982

3.48

148.76

1.4

1.2

14.18

10.79

e6/l

0.51

476

750

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

782

1304

3.10

146.56

1.9

0.24

0.22

g/l

8.09

751

1251

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

802

1359

3.05

146.52

1.9

1.22

1.13

g/l

11.97

774

1306

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

498

595

4.29

146.27

1.6

1.2

—

(3014051) Protein [Presence] in Urine by Test strip

5825

20945

1.56

145.55

2.7

2.1

0.07

0.02

0.49

242

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

519

650

4.09

144.22

1.6

1.2

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

1386

3170

2.29

143.31

2.6

1.5

80.18

84.90

ml/min/173m2

3.44

570

1045

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

656

988

3.42

143.20

1.3

1.1

3.71

3.44

mmol/l

8.25

618

939

(3047181) Lactate [Moles/volume] in Blood

514

649

4.06

141.43

6.4

2.5

1.30

1.17

mmol/l

2.46

442

566

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1368

3146

2.27

139.60

2.4

1.7

0.34

0.23

e6/l

0.93

1286

2951

(3023323) Follitropin [Units/volume] in Serum or Plasma

1968

5245

1.98

138.88

1.5

1.3

19.32

24.20

iu/l

8.89

1639

4594

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

715

1165

3.16

138.85

2.1

2.0

3.68

3.20

iu/l

0.57

330

514

(3002256) Pathology report gross observation

2195

6080

1.92

138.84

1.2

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

179

18.90

138.83

2.1

2.8

14.95

22.76

umol/l

2.81

179

(3007566) Smooth muscle Ab [Titer] in Serum

770

1321

3.01

137.80

1.3

1.4

88.94

129.11

titre

0.46

123

(3021879) Hepatitis B virus core Ab [Presence] in Serum

2551

7453

1.83

137.11

1.6

1.5

—

(3044290) Cell count panel - Cerebral spinal fluid

624

939

3.42

136.33

1.5

1.1

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

814

1454

2.89

136.22

1.6

1.7

7.21

13.01

iu/ml

1.25

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

383

5.10

135.93

3.1

1.5

952.62

31557.78

u/ml

0.49

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

1506

3651

2.16

135.67

1.4

—

(3011985) Renin [Units/volume] in Plasma

310

246

6.42

135.27

1.8

1.7

82.10

42.81

mu/l

1.04

284

229

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

365

350

5.32

134.91

2.7

1.5

35.90

21.84

mg/l

5.02

303

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

1381

3240

2.23

134.45

2.1

1.6

36.35

42.23

nmol/l

12.77

1350

3214

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

461

556

4.24

133.90

1.3

1.1

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

365

353

5.28

133.81

2.7

1.5

41.08

28.05

mg/l

2.68

303

306

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

510

675

3.87

132.36

1.7

1.2

3.69

3.62

g/l

0.51

493

630

(3034770) Mitochondria Ab [Titer] in Serum

739

1267

3.01

132.34

1.3

511.33

1496.49

titre

2.45

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

510

676

3.87

132.11

1.7

1.2

7.22

6.96

g/l

2.10

493

630

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

510

676

3.87

132.11

1.7

1.2

4.32

4.25

g/l

0.81

492

631

(3042517) Benzodiazepines panel - Urine

132

66.78

130.35

2.7

1.9

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

1046

2193

2.47

129.94

2.2

1.6

200.85

216.73

pmol/l

3.64

993

2142

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

497

657

3.87

129.17

1.7

1.2

2.90

2.69

g/l

3.56

480

611

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

304

250

6.19

128.82

1.2

32.89

34.27

nmol/l

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

925

1836

2.61

127.95

2.0

40.52

41.26

u/l

0.48

857

1774

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

477

617

3.96

127.39

5.7

2.0

503.16

682.79

iu/ml

0.20

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

456

569

4.10

127.23

1.8

1.3

0.33

0.11

g/l

2.30

417

512

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

685

1151

3.06

126.66

2.6

1.9

3.59

3.63

g/l

0.21

654

1093

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

288

228

6.43

125.92

1.5

1.4

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

590

905

3.35

125.34

1.2

1.1

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

676

1135

3.06

125.14

4.3

2.7

1.32

1.02

mg/l

21.63

639

1073

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

318

288

5.62

123.93

2.6

1.4

1.81

1.22

ratio

0.99

171

158

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

287

233

6.27

122.93

1.4

1.2

413.44

310.93

pmol/l

2.09

249

207

(3013139) Helicobacter pylori Ag [Presence] in Stool

1609

4159

2.03

122.67

1.2

—

(4146454) Self-monitoring of blood glucose

141

27.44

121.14

2.5

1.4

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

393

450

4.46

121.06

1.7

1.2

0.00

g/l

0.50

353

412

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

413

496

4.25

120.53

1.7

1.2

0.02

0.00

g/l

0.57

385

467

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

519

750

3.54

119.93

1.8

1.4

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

326

316

5.25

119.26

1.7

1.2

—

(3005322) IgE [Units/volume] in Serum or Plasma

1851

5083

1.92

119.06

1.3

330.76

250.33

u/ml

0.74

1721

4777

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

721

1311

2.83

116.84

1.3

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

3603

12073

1.61

116.81

2.5

2.1

—

(3039000) Anion gap in Blood by calculation

316

307

5.24

115.35

8.2

3.7

11.63

11.48

mmol/l

0.23

282

269

(3018572) Chloride [Moles/volume] in Blood

316

308

5.22

114.99

8.2

3.6

105.06

105.43

mmol/l

0.49

282

270

(3052851) Hemolysis interference index of Serum or Plasma

520

782

3.40

113.62

2.6

1.9

1.35

2.47

index

1.56

265

366

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

436

576

3.87

113.38

1.8

1.2

10.19

10.29

g/l

0.18

418

527

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1685

4555

1.94

113.15

2.4

2.3

17.26

20.21

au/ml

1.23

204

817

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

3080

9996

1.65

112.83

2.3

2.0

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

560

894

3.21

112.05

1.1

1.0

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1100

2548

2.24

109.74

1.5

1.2

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1577

4209

1.96

109.65

1.3

48.21

48.80

au/ml

0.03

320

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

1418

3644

2.03

109.34

2.1

1.8

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

2015

5846

1.81

109.09

2.5

2.2

5560.49

7155.69

u/l

1.31

693

2742

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

389

484

4.10

108.89

1.1

117.56

116.02

0.38

355

416

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

364

430

4.32

108.26

1.7

1.2

0.00

g/l

-0.00

353

411

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

369

446

4.22

106.89

1.7

1.5

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

289

278

5.29

106.51

1.2

1.4

0.16

0.11

nmol/l

—

(3045716) Anion gap in Serum or Plasma by calculation

217

148

7.44

106.27

3.6

2.2

10.58

10.46

mmol/l

0.13

210

148

(3020961) Endomysium IgA Ab [Titer] in Serum

1457

3846

1.98

104.29

1.1

79.02

206.11

titre

2.00

145

(3023420) DNA double strand Ab [Units/volume] in Serum

969

2171

2.31

104.14

2.0

1.8

6.02

6.66

iu/ml

0.29

250

506

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

306

321

4.85

103.51

1.4

1.2

27.48

13.20

u/l

1.01

262

294

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

379

484

3.99

102.80

1.3

1.1

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

379

485

3.98

102.54

1.3

1.1

—

(3045414) Leukocytes [Presence] in Urine

1698

4768

1.86

101.43

2.0

1.6

0.02

0.04

estimate

0.96

400

1274

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

283

284

5.07

100.11

1.2

1.4

0.55

0.49

nmol/l

1.19

275

271

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

257

237

5.51

98.55

1.5

1.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

425

615

3.53

97.99

3.2

3.0

566.45

82.75

u/ml

0.77

354

532

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

590

1062

2.85

97.18

1.9

2.1

10.79

9.92

mg/l

1.10

561

1024

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1692

4831

1.83

95.75

1.1

1.0

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

446

684

3.33

94.69

2.6

—

(3025941) Bacteria identified in Stool by Culture

1434

3903

1.91

93.74

1.2

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

444

688

3.29

92.85

2.1

1.9

135.81

137.26

g/l

0.63

368

560

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

306

357

4.36

92.33

1.9

1.2

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

458

728

3.21

92.20

1.5

1.2

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

330

414

4.06

91.48

2.2

3.1

22.20

23.88

nmol/l

1.33

311

407

(4195642) Thrombophilia screening test

378

530

3.63

90.97

1.2

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1007

2429

2.14

90.88

1.6

1.7

9.91

10.53

u/ml

0.14

254

898

(3042111) Morphology [Interpretation] in Bone marrow Narrative

195

143

6.91

90.58

1.6

1.1

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

292

338

4.39

88.90

1.4

1.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

417

638

3.33

88.84

1.2

3.29

3.43

u/ml

0.04

152

256

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

270

291

4.71

88.83

1.1

1.0

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

244

238

5.20

88.78

1.9

1.4

1833710.59

368883.13

iu/ml

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

372

525

3.61

88.75

1.5

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

399

593

3.43

88.63

1.3

1.2

3.23

4.92

u/ml

0.71

175

287

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

256

267

4.87

87.15

1.6

1.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

403

612

3.36

86.80

1.1

—

(3000012) Reticulocyte production index

186

137

6.88

86.12

1.8

1.2

0.92

0.81

1.09

118

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

235

228

5.23

85.95

1.2

1.4

0.18

0.17

nmol/l

0.50

181

176

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1901

5806

1.71

85.42

4.1

2.7

30.23

32.08

9.83

1403

4201

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

615

1216

2.59

85.36

1.3

1.2

—

(3037121) Protein [Mass/volume] in Urine

612

1207

2.60

85.36

3.4

3.1

305.16

461.92

mg/l

0.64

298

507

(3037756) Immunofixation for Serum or Plasma

217

195

5.64

85.23

1.6

1.2

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

287

340

4.29

85.12

1.1

99.40

94.62

1.71

272

310

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

5425

20952

1.41

84.98

1.8

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

574

1106

2.66

83.64

1.6

366.32

349.98

mu/l

0.30

452

924

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

721

1579

2.34

81.22

1.3

31.66

39.48

u/ml

0.27

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

289

360

4.08

80.83

1.6

1.5

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

212

201

5.35

79.28

3.9

1.2

55.67

140.21

u/ml

0.68

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

706

1557

2.33

78.30

1.5

0.40

0.51

nmol/l

1.21

528

1301

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

699

1535

2.34

78.25

1.3

1.2

37.24

36.90

u/ml

0.01

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

337

491

3.49

77.00

1.3

1.5

4.12

3.36

u/ml

—

(3006653) Thiamine [Moles/volume] in Blood

155

104

7.54

76.87

1.5

1.2

137.57

132.03

nmol/l

0.57

155

104

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

521

1002

2.66

76.17

1.5

1.4

8.67

7.10

iu/ml

0.17

(3004809) Band form neutrophils/Leukocytes in Blood

262

319

4.17

75.31

3.1

1.9

1.32

1.37

0.06

238

286

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

661

1442

2.35

75.05

1.3

1.2

233.42

220.59

u/ml

0.60

411

914

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

926

2330

2.05

74.84

1.3

—

(3016244) Insulin [Units/volume] in Serum or Plasma

279

360

3.94

74.78

3.5

3.6

32.23

25.37

mu/l

1.62

261

337

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

558

1126

2.53

74.41

1.4

1.2

19.54

20.00

u/l

0.12

464

951

(3016038) Potassium [Moles/volume] in Urine

132

9.02

73.61

1.5

1.4

36.98

35.04

mmol/l

0.23

122

(3048929) Epstein Barr virus Ab [Presence] in Serum

1234

3473

1.84

72.35

1.3

1.2

—

(3003694) ABO and Rh group [Type] in Blood

6094

24511

1.36

72.17

1.6

1.7

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

664

1479

2.30

72.01

1.3

3.12

10.22

u/ml

1.57

141

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1152

3178

1.87

71.81

1.4

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

450

828

2.77

71.29

1.5

1.7

0.67

0.79

g/l

1.70

350

679

(3014765) Yersinia sp identified in Stool by Organism specific culture

664

1491

2.28

70.71

1.2

1.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

662

1486

2.28

70.55

1.3

12.27

11.71

u/ml

0.05

207

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

661

1485

2.28

70.31

1.2

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

666

1505

2.27

69.91

1.2

1.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

592

1269

2.39

69.77

1.2

29.44

46.94

u/ml

1.31

108

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

385

656

2.99

69.51

1.4

1.2

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

157

128

6.21

67.14

1.7

1.4

2.52

1.44

nmol/l

0.67

116

100

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

2591

9037

1.51

66.57

1.8

2.0

—

5.70

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

565

1219

2.37

65.66

1.4

1.2

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

565

1222

2.36

65.32

1.4

1.2

25.00

22.10

u/ml

0.12

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

149

118

6.39

65.26

1.5

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1583

4934

1.67

65.23

1.6

1.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

236

299

4.00

64.74

1.7

1.1

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

372

649

2.92

64.61

1.1

1.45

1.38

g/l

2.41

343

603

(44790049) Parainfluenza type 3 nucleic acid detection

267

375

3.61

64.19

1.5

1.2

—

(44806118) Parainfluenza type 4 nucleic acid detection

267

375

3.61

64.19

1.5

1.2

—

(44790048) Parainfluenza type 2 nucleic acid detection

267

376

3.60

63.97

1.5

1.2

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

534

1137

2.40

63.82

1.2

1.3

10.78

22.29

u/ml

—

(40768795) Lymph node Pathology biopsy report

146

116

6.37

63.79

1.2

—

(44790047) Parainfluenza type 1 nucleic acid detection

267

377

3.59

63.74

1.5

1.2

—

(1617658) Protocol used for examination of sentinel lymph nodes

59.96

63.43

1.0

—

(3016750) Collection duration of Urine

14.49

62.89

2.2

2.3

512.09

528.08

min

0.41

(3020911) Cortisol [Moles/time] in 24 hour Urine

122

7.90

62.60

1.5

1.2

88.35

84.88

nmol/24h

0.14

122

(3044242) Glucose [Moles/volume] in Arterial blood

104

10.10

61.98

2.9

1.4

7.68

6.36

mmol/l

3.09

104

(3008037) Lactate [Moles/volume] in Venous blood

286

436

3.33

61.33

2.8

1.5

1.58

1.29

mmol/l

3.31

275

429

(3008898) HLA-B27 [Presence]

1200

3523

1.76

61.08

1.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

584

1322

2.26

61.03

1.9

1.7

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

256

362

3.59

61.01

1.1

287.97

278.00

mg/l

0.86

233

340

(3045142) Bone marrow Pathology biopsy report

124

7.37

60.64

1.4

1.1

—

(4268621) Lupus anticoagulant assay

288

445

3.29

60.56

2.3

2.2

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

230

303

3.85

60.14

1.4

1.1

1.91

1.73

mmol/l

1.46

217

287

(3003129) Base excess in Capillary blood by calculation

204

244

4.24

59.95

1.6

1.4

0.43

0.66

mmol/l

0.40

194

226

(3000093) Morphology [Interpretation] in Blood Narrative

177

186

4.82

59.91

1.2

1.1

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

528

1153

2.34

59.78

1.3

4.66

7.47

u/ml

0.25

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

630

1487

2.17

59.69

2.1

1.7

—

(3042733) HLA Ab [Presence] in Serum

17.33

59.68

4.3

3.2

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

529

1158

2.33

59.58

1.4

1.2

142.00

145.38

au/ml

0.22

138

318

(3003434) Protein [Mass/volume] in Pleural fluid

124

7.12

59.14

1.7

1.4

36.51

43.27

g/l

3.95

110

(3027135) IgG subclass 1 [Mass/volume] in Serum

292

468

3.17

58.13

1.3

6.31

6.74

g/l

1.54

210

347

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

370

685

2.75

58.02

1.2

—

(3035715) Granulocytes [#/volume] in Blood

442

900

2.50

57.90

3.4

4.08

3.69

e9/l

3.49

442

900

(3024139) IgG subclass 3 [Mass/volume] in Serum

291

467

3.16

57.82

1.3

0.37

0.43

g/l

0.84

206

349

(3028192) IgG subclass 2 [Mass/volume] in Serum

291

467

3.16

57.82

1.3

2.98

3.20

g/l

1.04

208

347

(3023410) Appearance of Cerebral spinal fluid

299

492

3.09

57.14

1.7

1.3

—

(3040151) Glucose [Moles/volume] in Capillary blood

229

313

3.71

57.13

7.5

1.6

7.43

5.74

mmol/l

6.96

200

244

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

202

250

4.09

57.05

1.6

1.2

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

16114

75713

1.36

56.81

19.5

6.6

333.99

334.34

g/l

4.81

16042

75100

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

317

544

2.96

56.62

1.1

1.0

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

104

8.61

56.47

1.5

1.2

13.20

14.16

pmol/l

0.89

(3035933) Granulocytes/Leukocytes in Blood

533

1201

2.26

56.29

3.3

2.9

57.86

56.97

0.91

533

1201

(3000034) Microalbumin [Mass/volume] in Urine

137

118

5.87

55.99

3.1

1.5

38.63

59.11

mg/l

0.36

(3002079) Sodium [Moles/time] in 24 hour Urine

126

6.43

55.60

1.4

176.13

150.05

mmol/24h

1.63

126

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

218

293

3.77

55.59

4.0

3.0

1200.05

26.27

u/ml

0.53

202

270

(40757494) Bilirubin.total [Moles/volume] in Blood

102

8.58

55.29

2.2

1.5

23.37

14.91

umol/l

—

(4062490) Immunoglobulin typing, IgG

285

465

3.11

55.21

1.3

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

264

411

3.26

54.93

1.1

1.0

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

333

600

2.82

54.79

1.2

248.57

105.00

titre

—

(3017569) Oxygen content in Arterial blood

9.68

54.76

2.8

1.7

16.63

18.06

2.09

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

206

269

3.88

54.50

1.4

10.96

10.06

umol/l

1.15

191

261

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

178

206

4.37

54.35

1.6

1.2

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

326

585

2.83

54.02

1.2

532.00

408.95

titre

0.24

(3012441) Differential panel - Pleural fluid

109

7.44

53.71

1.7

1.4

—

(3049717) Cytology report of Urine Cyto stain

399

802

2.53

53.65

2.1

—

(3011412) CD3 cells [#/volume] in Blood

237

349

3.44

53.46

2.9

2.3

1355.51

1350.78

e6/l

0.02

200

291

(21494755) Public health laboratory ask at order entry panel

2396

16407

0.70

53.12

1.3

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

9.87

53.02

1.3

1.1

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

306

536

2.90

52.85

1.2

1.1

34.56

42.50

mg/l

2.26

247

448

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

3841

14988

1.36

51.92

3.8

2.9

1.44

1.59

ug/l

3.77

3482

14126

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

119

6.20

50.99

1.5

1.2

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

148

154

4.86

50.67

1.6

1.2

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

148

154

4.86

50.67

1.6

1.2

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

148

154

4.86

50.67

1.6

1.2

—

(4094501) Cardiovascular stress test using bicycle ergometer

471

1055

2.27

50.43

1.1

1.0

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

191

250

3.87

50.42

2.4

2.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

2612

17483

0.71

50.18

1.8

1.7

3.57

3.50

ratio

1.87

1899

12827

(3045424) Erythrocytes [Presence] in Urine

886

2518

1.80

50.03

2.1

1.5

0.01

0.03

estimate

0.95

315

1081

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

294

522

2.86

49.65

1.1

219.91

228.18

mg/l

0.33

256

467

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

122

107

5.76

49.13

1.5

1.2

—

(40768806) Pleura Pathology biopsy report

101

7.28

49.06

1.8

1.5

—

(40768443) Skin Pathology biopsy report

810

2260

1.84

48.48

1.2

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

167

203

4.16

48.25

1.6

1.5

5.98

5.02

u/l

0.82

149

186

(3024932) HLA-DR beta [Type]

16.38

48.17

1.1

1.0

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

1968

13740

0.69

48.07

1.6

1.5

3.45

3.56

mmol/l

3.82

1294

8908

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

121

108

5.66

47.98

1.5

1.2

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

282

500

2.86

47.75

1.1

1.0

—

(3004451) EKG impression Narrative

11.66

47.57

1.4

1.1

—

(3024471) HLA-A [Type]

15.12

47.48

1.0

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

250

414

3.06

47.37

1.3

1.2

0.64

0.77

ratio

1.40

139

240

(3017354) Segmented neutrophils/Leukocytes in Blood

172

218

3.99

47.28

3.0

1.9

53.65

53.73

0.02

151

192

(21494890) Protein electrophoresis panel - 24 hour Urine

105

6.54

47.07

2.1

1.4

—

(3042631) Mycobacterium sp identified in Specimen

171

217

3.99

46.94

2.3

3.3

—

(3020876) Protein [Mass/time] in 24 hour Urine

152

175

4.39

46.75

2.7

2.5

1.54

1.57

g/24h

0.03

100

(3029634) Reagin Ab [Titer] in Serum by VDRL

526

1279

2.10

46.31

2.3

2.2

18.33

7.38

titre

0.71

(3006922) Hepatitis E virus Ab [Presence] in Serum

253

429

2.99

46.17

1.1

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

323

630

2.60

46.08

1.3

68.90

28.99

u/ml

0.90

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

241

397

3.08

46.06

1.2

1.3

—

12.00

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

959

2863

1.72

45.83

2.4

1.6

36.21

25.17

u/ml

1.80

922

2776

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

466

1084

2.19

45.74

2.0

1.8

5328.00

3465.60

titre

0.32

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

223

353

3.20

45.34

1.1

—

0.30

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

169

219

3.90

45.22

2.2

2.0

100.78

103.58

0.40

162

196

(3023419) Bacteria identified in Sputum by Culture

198

293

3.42

44.44

2.6

3.3

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

285

532

2.72

44.13

1.3

1.2

6.12

6.51

umol/l

0.76

250

472

(21494434) Karyotype in Bone marrow

7.21

43.44

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

161

208

3.91

43.27

1.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

150

184

4.12

42.93

2.7

2.8

49.99

52.63

umol/l

0.47

134

178

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

6.34

42.88

1.3

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

63.52

42.55

1.1

1.0

—

(40768446) Kidney Pathology biopsy report

6.59

42.41

1.7

1.3

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

6.85

42.32

1.5

1.3

426.25

877.59

u/l

1.74

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

263

482

2.77

42.10

1.4

1.2

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1119

3563

1.61

41.91

1.7

1.3

4.17

3.40

mg/l

1.82

881

2085

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

257

467

2.79

41.77

1.4

1.2

—

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

159

210

3.83

41.58

1.2

1.1

69.23

91.20

1.55

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

369

809

2.32

41.49

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

137

162

4.27

40.94

1.1

1.0

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

256

471

2.75

40.71

1.4

1.2

—

(3023199) Leukocytes [#/volume] in Pleural fluid

104

5.53

40.45

1.6

1.3

3131.17

5648.83

e6/l

1.33

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

133

155

4.33

40.41

1.9

2.1

27.30

27.89

umol/l

0.24

123

143

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

775

2257

1.76

40.31

1.1

3.78

5.52

eliau/ml

0.94

106

405

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

126

141

4.51

40.05

1.0

256.77

357.34

ng/l

2.78

110

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

125

139

4.54

40.00

1.0

36.45

47.04

ng/l

1.27

106

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

142

179

4.01

39.37

1.1

1.0

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

311

645

2.45

39.37

1.1

1.2

14.33

18.40

u/ml

0.14

(3036782) Glucose [Moles/volume] in Pleural fluid

124

139

4.51

39.35

1.5

1.2

5.93

5.03

mmol/l

2.84

113

126

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

124

140

4.47

39.04

1.0

835.67

709.12

ng/l

1.58

104

(3045788) Cell count panel - Pleural fluid

6.02

39.00

1.7

1.3

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

726

2097

1.77

38.82

1.2

4.59

4.29

0.33

123

481

(3007463) Buprenorphine [Presence] in Urine

58.47

38.81

5.2

4.0

—

(3038515) Glucose [Moles/volume] in Venous blood

217

374

2.94

38.63

2.9

1.6

7.15

6.11

mmol/l

6.00

208

369

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

103

5.30

38.60

1.9

1.2

—

(3010838) Calcium [Moles/time] in 24 hour Urine

314

661

2.41

38.55

2.0

2.1

5.46

5.73

mmol/24h

0.66

288

628

(3008757) Leukocyte morphology finding [Identifier] in Blood

156

216

3.65

38.41

3.1

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

243

450

2.74

38.23

1.4

1.2

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

242

449

2.73

37.95

1.4

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

241

451

2.71

37.22

1.2

1.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

239

448

2.70

36.80

1.4

1.2

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

208

362

2.91

36.46

1.1

1.2

113.17

124.04

pmol/l

2.27

208

362

(3028308) Erythrocytes [#/volume] in Pleural fluid

5.68

35.92

1.6

1.3

31608.04

56520.60

e6/l

0.32

(4024509) Urine culture

754

2258

1.70

35.58

1.8

1.5

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

146

204

3.62

35.55

1.9

2.0

1.89

1.83

umol/l

0.37

134

188

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

179

289

3.13

35.42

3.1

2.3

598.64

506.18

e6/l

0.78

138

222

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

126

159

4.00

34.94

1.9

1.2

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

149

215

3.50

34.75

1.1

1.08

7.64

nmol/l

1.16

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

8.49

34.59

2.1

1.1

189.00

4.45

ug/min

0.93

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

159

242

3.32

34.39

1.2

66.40

65.01

u/l

0.07

138

214

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

253

508

2.52

34.24

1.3

1.5

—

titre

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

221

415

2.70

33.96

1.2

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

202

361

2.83

33.89

1.1

0.99

1.05

u/l

0.72

122

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

178

295

3.05

33.83

3.1

2.3

220.10

229.84

e6/l

0.24

143

238

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

219

411

2.70

33.70

1.2

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

103

113

4.60

33.52

1.2

1.1

19.44

7.33

—

(3047189) Immunofixation for 24 hour Urine

10.46

32.93

1.8

1.3

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

11.99

32.64

2.5

1.6

513.59

1680.00

e6/l

0.52

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

170

282

3.05

32.29

1.1

1.06

1.05

ratio

0.38

141

229

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

885

6709

0.65

32.14

1.1

0.64

ratio

0.02

566

(3010375) cycloSPORINE [Mass/volume] in Blood

5.30

31.52

21.9

12.7

117.82

116.28

ug/l

0.05

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

5.61

31.27

1.5

1.8

0.90

0.99

nmol/l

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

+∞

31.22

1.8

0.0

33.95

—

nmol/l

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

217

424

2.59

31.01

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

213

413

2.61

30.89

1.1

—

(40768441) Liver Pathology biopsy report

141

213

3.34

30.88

1.6

1.3

—

(40768800) Prostate Pathology biopsy report

147

229

3.24

30.77

1.3

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

571

1646

1.77

30.76

1.6

1.4

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

179

316

2.86

30.72

1.3

1.4

74.01

72.48

0.75

169

302

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

8.12

30.49

3.2

1.3

1.30

0.64

1.66

(4034850) Laboratory test

575

1667

1.76

30.39

10.0

4.1

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

176

310

2.87

30.32

1.3

1.4

494.50

499.58

mu/l

0.02

166

296

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

212

416

2.58

30.07

1.1

—

(3017704) Immunofixation for Urine

7.06

30.06

1.5

1.3

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

212

417

2.57

29.93

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

205

397

2.61

29.82

1.2

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

172

306

2.84

29.15

1.7

1.5

22.08

22.47

umol/l

0.06

160

292

(3018333) Ribosomal P Ab [Presence] in Serum

198

383

2.61

28.88

1.1

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

6.42

28.87

4.5

2.4

10.24

10.67

kpa

0.52

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

6.42

28.87

4.5

2.4

4.90

4.74

kpa

0.59

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

203

398

2.58

28.86

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

846

2756

1.57

28.71

1.3

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

5.89

28.56

1.6

1.8

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

5.89

28.56

1.6

1.8

—

(3000330) Specific gravity of Urine by Test strip

679

2106

1.64

28.14

2.7

2.1

1.02

ratio

0.11

597

1819

(3026389) Candida sp identified in Specimen by Organism specific culture

345

869

2.01

27.86

1.3

1.2

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

5.92

27.86

2.9

1.4

0.62

0.64

mmol/l

1.42

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

487

1379

1.79

27.85

1.1

—

1.19

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

114

160

3.60

27.71

1.2

1.1

4.10

3.21

iu/ml

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

+∞

27.31

1.5

0.0

624.13

—

nmol/l

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

193

381

2.56

27.11

1.3

1.2

88.29

69.92

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

228

490

2.35

26.94

1.2

1.3

3.13

4.04

u/ml

0.37

122

285

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1827

11866

0.75

26.73

1.5

1.6

1024.06

1029.25

mu/l

0.07

1514

10326

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

194

389

2.52

26.45

1.2

1.3

143.10

241.19

titre

0.83

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

194

389

2.52

26.45

1.2

1.3

102.50

388.00

titre

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

116

172

3.40

26.16

1.0

1.1

95.44

92.96

0.35

121

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

163

300

2.75

26.09

3.3

2.4

0.78

0.80

e9/l

0.22

157

294

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

119

3.98

26.08

1.3

1.1

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

10.31

26.06

1.4

1.1

10.63

10.04

g/l

0.07

(3022621) pH of Urine by Test strip

1443

5338

1.39

25.80

2.3

1.8

6.17

6.22

1.15

872

3097

(3019420) Tryptase [Mass/volume] in Serum or Plasma

189

380

2.51

25.65

1.4

7.01

6.88

ug/l

0.03

168

340

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

115

172

3.37

25.63

1.5

1.4

—

(3006270) Folate [Moles/volume] in Blood

149

264

2.85

25.50

1.1

413.06

402.46

nmol/l

0.22

140

255

(3044007) Cell count panel - Peritoneal fluid

11.19

25.28

2.3

1.6

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

9.23

25.08

1.1

0.65

0.83

umol/24h

0.94

(3035880) pH of Pleural fluid

7.08

24.92

1.5

1.3

7.30

0.04

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

124

199

3.15

24.92

2.8

1.7

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

777

2565

1.54

24.90

1.6

0.29

0.51

iu/ml

0.32

119

426

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

103

4.16

24.87

1.9

1.2

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

103

4.16

24.87

1.9

1.2

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

103

4.16

24.87

1.9

1.2

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

103

4.16

24.87

1.9

1.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

403

1120

1.83

24.52

1.5

1.4

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

8.86

24.49

1.3

1.4

93.25

34.81

ng/l

0.36

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

125

204

3.09

24.48

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

124

3.78

24.23

1.1

1.0

—

(3000475) Leukocytes [#/volume] in Synovial fluid

375

1023

1.86

24.17

1.7

10521.05

10574.83

e6/l

0.01

256

751

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

118

3.85

23.95

1.3

1.1

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

10.07

23.95

1.8

1.5

1913.15

17855.57

e6/l

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

137

240

2.88

23.93

4.2

5.3

—

(40765096) Chromosome analysis panel by Banding

8.52

23.91

1.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

109

3.98

23.87

2.6

3.1

26.76

26.94

umol/l

0.04

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

6.33

23.76

1.3

1.1

1.18

1.16

mmol/l

1.09

(3001186) Copper [Moles/volume] in Serum or Plasma

131

3.66

23.70

1.5

1.3

17.04

15.85

umol/l

1.32

113

(3044927) Protein electrophoresis panel - Urine

131

3.66

23.70

1.2

1.1

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

713

2335

1.55

23.67

1.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

107

162

3.33

23.48

1.1

95.27

97.49

0.25

(3004716) Salmonella sp identified in Stool by Organism specific culture

1347

5003

1.38

23.46

1.3

1.5

—

(3004616) Nuclear Ab [Presence] in Serum

246

582

2.14

23.40

1.3

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

11.33

22.90

1.1

1.3

46.33

34.38

mg/l

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

108

168

3.24

22.79

1.2

113.77

115.15

0.10

102

150

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

4.82

22.71

1.1

1.0

82.14

78.30

ug/l

0.29

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

857

2950

1.48

22.59

1.1

2.75

2.67

u/ml

0.06

473

1544

(3017315) Amylase [Enzymatic activity/volume] in Urine

120

202

3.00

22.42

1.3

1.1

480.29

382.79

u/l

0.24

109

193

(3028717) Thiamine [Mass/volume] in Blood

6.27

22.28

1.4

1.2

61.75

69.61

ug/l

0.82

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

107

168

3.21

22.28

1.6

2.2

141.84

116.65

3.02

101

159

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

144

271

2.68

22.23

1.6

1.8

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

4.24

22.17

1.1

1.0

—

(3000060) B lymphocytes [#/volume] in Blood

104

161

3.26

22.12

2.6

2.2

0.22

0.15

e9/l

1.18

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

8.76

22.11

5.4

4.7

39.30

37.43

ug/min

0.03

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

1238

4580

1.38

22.06

1.4

1.3

231.98

233.16

miu/ml

0.04

589

2446

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

4.32

22.04

1.4

1.1

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

4.32

22.04

1.4

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

103

159

3.27

22.00

1.1

100.18

99.37

0.06

(3014148) Varicella zoster virus Ab [Titer] in Serum

461

1379

1.70

21.94

1.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.27

21.76

1.1

1.0

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

120

207

2.93

21.56

1.3

1.2

0.30

0.29

g/l

0.90

167

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

121

210

2.91

21.52

2.7

3.2

46.09

43.95

0.53

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

127

227

2.82

21.49

1.1

1.2

27.92

5.89

u/ml

0.42

(43055514) Macroprolactin [Presence] in Serum or Plasma

135

250

2.73

21.47

1.3

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

4.05

21.07

2.6

2.3

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

6.40

20.90

2.6

4.6

1.07

0.96

mmol/l

0.11

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

6.40

20.90

2.6

3.8

39.69

29.36

mg/l

0.14

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

124

223

2.81

20.78

1.2

1.3

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

520

1632

1.62

20.65

1.1

14.40

13.55

au/ml

0.13

146

636

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

114

196

2.93

20.62

1.3

1.2

109.77

107.67

0.35

180

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

4.33

20.59

1.1

1.0

—

(21494814) CD8 cells/Lymphocytes in Specimen

118

3.59

20.51

2.2

2.1

31.17

27.11

1.69

118

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

109

3.70

20.34

1.2

1.1

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

9.06

20.33

1.4

1.3

21.40

20.32

g/l

0.07

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

3.96

20.20

1.1

1.0

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

3880

16753

1.20

20.12

1.6

1.5

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

133

3.37

19.97

1.2

98.76

69.24

u/l

1.34

110

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

334

936

1.81

19.88

1.1

0.94

1.12

0.14

(3035320) C reactive protein [Mass/volume] in Body fluid

174

382

2.30

19.78

2.8

1.8

27.91

29.37

mg/l

0.15

123

256

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

3.87

19.69

1.1

1.0

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

517

1640

1.60

19.69

1.3

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

106

181

2.95

19.42

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

466

3639

0.64

19.31

1.3

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

729

2510

1.48

19.22

1.1

1.76

1.11

u/ml

0.88

343

1165

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

129

3.36

19.21

1.2

28.58

11.97

u/l

1.00

106

(3022689) Creatine [Moles/volume] in Urine

4.78

19.17

1.4

1.3

8.03

10.96

mmol/l

1.29

(3003888) Timothy IgE Ab [Units/volume] in Serum

754

2616

1.47

19.14

1.1

6.25

6.98

u/ml

0.47

420

1504

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

132

3.32

19.12

1.1

1.2

77.35

65.33

u/l

0.96

122

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

4.39

19.07

2.2

1.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

4.39

19.07

2.2

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

5.96

18.92

1.3

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

102

173

2.97

18.91

1.2

1.3

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

156

334

2.36

18.75

1.1

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

+∞

18.73

1.9

0.0

294.58

—

ug/l

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

129

3.32

18.68

1.1

1.2

18.01

10.54

u/l

1.50

117

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

455

1418

1.63

18.62

1.4

155.90

47.30

pmol/l

1.88

439

1375

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

4.22

18.56

2.2

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

112

3.51

18.53

1.0

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

403

1219

1.68

18.49

1.1

2.33

2.92

0.55

286

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

3.79

18.42

1.7

1.3

41617.27

1528.00

u/ml

—

(37208534) Antinuclear antibody arbitrary concentration in serum

150

3.09

18.17

1.1

1.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

741

2595

1.45

17.94

1.1

2.60

2.51

u/ml

0.06

403

1283

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

3.70

17.60

1.2

86.56

101.73

0.55

(3050129) First trimester maternal screen panel - Serum or Plasma

1181

7713

0.76

17.56

1.4

1.5

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

149

3.05

17.38

1.0

1.1

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

128

259

2.49

17.33

1.1

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

136

3.15

17.31

1.4

1.3

75.56

147.69

titre

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

6.33

17.25

1.2

283.89

292.46

pmol/l

0.05

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

140

3.10

17.06

1.5

1.4

4.58

6.47

u/l

0.83

117

(3034426) Prothrombin time (PT)

3.67

16.93

1.3

1.2

28.22

27.93

0.13

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

3.58

16.91

1.2

1.1

75.06

92.50

0.59

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2906

12390

1.21

16.88

3.3

2.7

20.97

22.50

4.16

938

4107

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

103

190

2.73

16.61

1.1

70.79

233.93

ng/l

0.72

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

101

3.49

16.57

1.4

1.3

138.78

121.23

nmol/l

0.27

(44813793) Dust mix specific IgE antibody measurement

208

531

1.98

16.41

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

425

1347

1.60

16.32

1.2

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

177

426

2.10

16.30

1.2

65.75

30.78

u/ml

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

7.67

16.29

2.4

1.2

7.21

5.52

mmol/l

0.76

(3048879) Bone marrow aspiration report

9.39

16.16

2.5

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

4314

19116

1.17

16.07

2.0

1.8

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

120

3.19

15.83

6.2

1.2

61.19

13922.71

mg/l

1.61

(3038177) Helicobacter pylori Ab [Presence] in Serum

435

1401

1.57

15.64

1.1

—

(3017509) Phencyclidine [Presence] in Urine

3.52

15.59

2.2

1.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

132

3.02

15.09

2.8

1.6

102.62

67.92

ng/l

2.61

132

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

5.85

14.94

1.3

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

242

676

1.81

14.69

3.2

2.2

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

4.37

14.40

1.2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

869

5762

0.75

14.35

1.5

1.7

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

317

969

1.65

14.10

2.5

2.6

26.86

31.19

iu/ml

0.21

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

7.42

13.95

1.1

1.2

57.48

117.00

ug/l

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

642

2301

1.42

13.80

1.1

5.85

4.63

u/ml

0.47

341

1170

(3051611) Lipemic interference index of Serum or Plasma

115

248

2.34

13.75

2.8

1.9

15.16

15.52

index

0.07

123

(40761539) Cells [Type] in Urine sediment by Light microscopy

4.03

13.71

1.4

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

297

900

1.67

13.67

1.1

1.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

119

3.01

13.55

1.5

1.7

8.29

8.48

ug/l

0.14

119

(3028433) Virus identified in Specimen by Culture

111

3.09

13.52

1.2

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

217

602

1.82

13.51

1.2

1.42

1.08

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

667

4555

0.73

13.43

1.5

57.72

60.80

ug/l

1.21

667

4555

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

169

2.62

13.29

1.3

1.4

16.85

27.46

u/ml

0.85

(3010370) Gastrin [Moles/volume] in Serum or Plasma

4.49

13.24

2.0

40.69

13.21

pmol/l

1.34

(3003329) Lymphocytes/Leukocytes in Synovial fluid

153

380

2.03

13.11

1.7

1.5

30.94

42.78

2.94

258

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

7.86

12.96

1.2

1.1

1.60

1.30

umol/24h

0.87

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

4.39

12.94

1.1

1.0

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

4.39

12.94

1.1

1.0

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

167

432

1.95

12.82

1.8

1.5

22.17

26.49

mg/l

0.54

160

(37021550) Renin [Units/volume] in Plasma --upright

5.03

12.72

1.4

1.8

262.50

55.04

mu/l

0.58

(3038026) Centromere Ab [Units/volume] in Serum

131

310

2.13

12.70

1.2

29.40

16.84

u/ml

—

(44806071) Cardiolipin IgM antibody measurement

3.97

12.68

1.1

—

(3014271) Vancomycin [Susceptibility]

4.03

12.59

2.8

1.9

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

117

266

2.22

12.49

2.4

1.3

26.16

809.18

ug/l

1.28

106

255

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

3.74

12.02

1.2

—

(3002619) Bacteria identified in Specimen by Culture

101

3.04

11.92

1.2

1.0

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

540

1929

1.42

11.88

1.1

0.56

0.42

u/ml

0.19

184

495

(3001556) Androgen free Index in Serum or Plasma

118

2.86

11.84

1.2

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

187

2.43

11.71

1.1

1.0

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

14.47

11.65

4.0

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

178

487

1.84

11.65

1.1

1.0

1588.82

1386.94

miu/ml

1.48

178

487

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

3.50

11.54

1.4

1.2

42.61

41.53

g/l

0.52

(3043410) Blood group antigens tested for on Red Blood Cells

109

2.91

11.48

1.3

1.1

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

4.03

11.48

2.1

2.8

1.29

1.22

umol/l

0.48

(3023430) Cat dander IgE Ab [Units/volume] in Serum

592

2165

1.39

11.40

1.1

8.95

5.22

u/ml

1.90

279

992

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

960

6094

0.78

11.38

1.4

1.5

1.17

ratio

0.00

569

3724

(44806420) Estimation of glomerular filtration rate

259

799

1.64

11.23

2.3

1.7

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

782

5086

0.76

11.23

1.5

1.6

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

964

6106

0.78

11.22

1.4

1.5

0.95

0.94

ratio

0.37

573

3735

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

964

6106

0.78

11.22

1.4

1.5

1.29

1.17

ratio

2.49

575

3766

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

944

5991

0.78

11.17

1.4

1.5

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

4.61

11.02

2.9

2.1

5.48

4.72

ug/l

0.25

(3037692) Legionella sp identified in Specimen by Organism specific culture

3.67

11.01

1.7

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

5.66

10.95

1.6

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

279

884

1.59

10.90

1.4

1.3

210.66

204.77

pmol/l

0.07

279

884

(4281824) Cell count and differential, peritoneal fluid

133

337

1.99

10.89

1.1

1.0

—

(3005033) Fetal Nuchal fold Thickness US

767

4975

0.77

10.80

1.5

1.26

1.25

0.35

535

3765

(3045683) HLA typing for celiac disease panel - Blood or Tissue

190

546

1.76

10.66

1.0

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

4.73

10.62

1.1

1.0

—

(3008536) Aspergillus sp Ab [Presence] in Serum

4.73

10.62

2.7

1.2

—

(3013727) Leukocytes other/Leukocytes in Blood

4.12

10.62

3.4

1.4

53.06

50.81

0.19

(3043238) Trisomy 21 risk [Likelihood] in Fetus

802

5157

0.77

10.55

1.5

1.6

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1035

6442

0.80

10.36

1.5

1.6

61.16

63.48

ug/l

0.83

861

5479

(3006571) Granulocytes/Leukocytes in Synovial fluid

186

538

1.74

10.23

1.6

61.46

46.99

4.52

110

383

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

425

1495

1.44

10.23

1.0

1.1

3.18

3.06

eliau/ml

0.07

219

913

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

+∞

10.14

6.2

0.0

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

154

2.45

10.06

2.8

1.4

153.04

115.93

ng/l

0.33

116

(3020491) Glucose [Moles/volume] in Blood

153

419

1.84

10.06

1.6

1.3

6.07

5.25

mmol/l

3.90

122

339

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

4.46

10.01

1.2

1.0

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

152

2.45

9.93

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

128

2.60

9.90

4.2

2.6

1.89

2.21

ratio

0.91

112

(3013637) Mi-2 Ab [Presence] in Serum

2.90

9.67

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.90

9.67

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.90

9.67

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.90

9.67

1.2

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

2.86

9.64

3.3

4.7

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

121

2.62

9.64

1.6

1.7

0.24

0.28

nmol/l

0.20

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

175

2.30

9.43

1.1

1.0

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

147

2.43

9.40

1.1

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

4.31

9.36

1.7

1.5

2.73

1.80

ug/l

0.51

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

11.18

9.27

3.6

1.9

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

11.18

9.27

1.1

1.0

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

207

636

1.64

9.21

1.1

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

5.25

9.13

1.1

1.0

—

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

4.29

9.01

1.2

1.1

42.00

79.94

2.21

(3032057) Clostridioides difficile [Presence] in Stool

4.29

9.01

2.0

1.6

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

141

2.43

8.99

2.1

2.8

—

(3024869) Neuronal Ab [Presence] in Serum

4.00

8.89

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

893

3592

1.26

8.87

1.4

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

2.97

8.76

1.2

1.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

121

322

1.89

8.74

1.1

14.27

14.68

u/ml

0.03

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

6.37

8.51

3.8

2.3

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

2.70

8.44

1.0

1.1

0.18

15.38

u/ml

0.51

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

166

493

1.70

8.42

1.5

1.3

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

9.56

8.26

3.4

1.8

—

(3034891) Synovial lining cells/cells in Synovial fluid

213

2.08

8.24

1.6

1.4

5.32

5.26

0.01

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

183

2.17

8.24

1.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

105

2.59

8.14

1.1

1.0

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

5.97

8.09

1.0

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

225

2.04

8.08

1.2

1.3

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

4.09

7.68

1.1

1.0

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

3.18

7.66

1.7

1.6

2.03

2.31

mg/l

0.11

(3026726) Creatinine [Moles/volume] in Specimen

11.50

7.61

2.7

1.0

206.44

224.57

umol/l

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

3.43

7.58

1.2

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

3.88

7.51

2.1

1.0

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

230

1696

0.68

7.43

1.4

1.6

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

3.23

7.41

1.3

1.2

0.74

0.61

iu/ml

0.10

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

12.57

7.41

3.3

1.0

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

110

301

1.84

7.38

1.2

1.1

9.72

13.39

u/ml

0.15

205

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.77

7.37

1.0

1.2

—

(3024263) Appearance of Synovial fluid

182

2.10

7.36

2.1

2.3

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.70

7.34

1.1

1.0

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

105

284

1.86

7.30

1.6

2.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

112

2.43

7.22

1.5

1.0

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

3.85

7.16

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

3.19

7.09

1.5

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

4.59

7.05

1.7

1.2

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

10.77

6.98

1.0

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

209

691

1.53

6.98

1.1

7.41

5.90

iu/ml

0.46

237

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

527

0.46

6.87

1.4

1.2

64.94

69.78

ug/l

0.30

527

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

3.05

6.85

1.7

1.6

0.63

3.41

mg/l

2.30

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

3.05

6.85

1.7

1.6

2.10

4.50

mg/l

1.13

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

3.05

6.85

1.7

1.6

1.57

1.71

mg/l

0.08

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

3.05

6.85

1.7

1.6

1.24

1.72

mg/l

0.27

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

3.05

6.85

1.7

1.6

2.54

1.91

mg/l

0.22

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

3.05

6.85

1.7

1.6

3.09

4.42

mg/l

0.47

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

3.05

6.85

1.7

1.6

3.75

6.35

mg/l

0.92

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

3.05

6.85

1.7

1.6

2.49

1.65

mg/l

0.30

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

3.05

6.85

1.7

1.6

0.75

1.18

mg/l

0.39

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.81

6.82

1.0

1.1

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.98

6.80

1.3

1.2

1.52

1.74

iu/ml

0.26

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

241

832

1.46

6.58

1.1

13.49

20.18

u/ml

2.35

112

382

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

145

447

1.63

6.52

1.0

14.71

13.46

u/ml

0.22

315

(3013166) Neutrophils/Leukocytes in Synovial fluid

2.52

6.50

1.5

1.3

39.69

53.24

1.27

(40757373) Influenza virus identified in Isolate

3.35

6.48

1.9

1.1

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

228

1.90

6.40

1.6

1.5

2.58

3.53

u/field

0.33

165

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

3.24

6.40

1.0

0.04

u/ml

0.13

(3028679) Herpes simplex virus Ab [Presence] in Serum

185

608

1.53

6.39

1.2

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

129

388

1.68

6.38

1.4

1.5

65719.81

78028.62

e6/l

0.13

242

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

4.55

6.34

1.0

1.1

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

8.38

6.24

1.0

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.66

6.24

1.2

1.0

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

+∞

6.24

6.8

0.0

472.50

—

umol/l

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

+∞

6.24

5.1

0.0

—

(3033942) Copper [Moles/time] in 24 hour Urine

4.06

6.20

1.0

1.7

0.67

2.11

umol/24h

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

10.89

6.14

1.0

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

6.58

6.14

1.0

29.97

23.13

u/l

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

3.49

6.13

2.1

2.0

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

2.66

6.10

1.3

1.1

212.54

100.43

mg/l

0.30

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

874

5228

0.83

5.97

2.1

1.9

—

(3022475) Manganese [Moles/volume] in Blood

5.03

5.89

1.4

0.17

0.15

umol/l

0.51

(3025018) Bordetella pertussis Ab [Titer] in Serum

197

673

1.48

5.73

1.2

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

3.06

5.71

2.0

2.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

3.87

5.59

1.1

1.2

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.43

5.57

1.0

1.2

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

3.98

5.50

1.1

1.0

8.53

6.08

u/l

0.52

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

100

295

1.71

5.37

1.8

1.7

2.41

1.94

u/field

0.40

161

(3019768) Coxiella burnetii Ab [Presence] in Serum

3.46

5.35

1.0

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.64

5.13

1.8

1.6

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

120

377

1.60

5.11

8.1

7.2

519.57

1695.43

u/ml

0.44

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

7.26

5.10

1.0

3.31

2.78

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

6.40

5.07

1.3

3.0

31.00

44.73

umol/l

1.52

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

4.07

5.06

1.2

1.0

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

2.45

5.01

1.7

1.6

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.64

4.99

1.4

—

(3025130) Human papilloma virus identified in Specimen

463

1858

1.26

4.88

1.9

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

7.54

4.84

1.4

1.0

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

253

1698

0.75

4.79

1.6

7.64

7.34

mmol/l

1.61

237

1625

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

2.36

4.78

1.2

1.1

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

2.41

4.75

1.5

0.35

0.39

ug/l

0.26

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

4.02

4.71

1.0

0.20

0.04

u/ml

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

+∞

4.68

1.0

0.0

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

10.05

4.68

1.4

3.4

3.79

1.73

mu/l

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

10.05

4.68

10.1

1.0

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

5.03

4.61

1.1

1.0

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

5.03

4.61

1.0

1.1

774.27

243.60

u/l

0.73

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

587

2438

1.22

4.54

1.4

1.2

3.34

ug/l

0.00

553

2333

(3041918) Cholesterol [Moles/volume] in Pleural fluid

3.97

4.35

1.3

1.4

1.57

2.62

mmol/l

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

3.56

4.33

1.1

1.0

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

8.38

4.32

3.6

5.7

—

(4015189) Microbial culture of sputum

2.67

4.30

3.4

1.5

—

(3018133) Calcium [Moles/volume] in Urine

131

1.96

4.29

1.6

3.2

2.51

2.94

mmol/l

0.74

124

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

6.91

4.27

1.0

—

(3041806) Other cells [#/volume] in Blood by Manual count

195

708

1.39

4.21

1.5

1.3

0.50

0.53

e9/l

0.91

195

708

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

4.69

4.12

1.0

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

4.69

4.12

1.0

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

528

2195

1.21

4.09

2.1

2.4

5.37

5.49

umol/l

0.07

384

1621

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

9.05

4.07

1.0

—

(3026480) Teichoate Ab [Titer] in Serum

5.03

4.06

1.1

1.0

—

(3050794) Legionella sp Ab [Presence] in Serum

3.23

4.04

1.2

—

(3019174) dRVVT (LA screen)

2.75

4.03

1.1

1.2

—

(3044009) aPTT.lupus sensitive (LA screen)

2.75

4.03

1.1

1.2

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

7.18

4.01

2.1

1.1

2.60

2.04

g/l

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

3.91

4.00

1.0

0.22

0.01

u/ml

—

(3016031) Almond IgE Ab [Units/volume] in Serum

2.11

3.99

1.0

0.85

1.01

u/ml

0.10

(3052592) Norovirus Ag [Presence] in Stool

2.96

3.94

1.1

1.3

—

(40760410) HLA-B [Type] by High resolution

+∞

3.90

1.0

0.0

—

(40760409) HLA-A [Type] by High resolution

+∞

3.90

1.0

0.0

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.69

3.88

1.9

1.7

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

137

1.87

3.82

1.0

0.86

0.33

u/ml

0.32

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

113

1.96

3.74

1.0

0.00

0.02

u/ml

1.82

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

2.29

3.71

1.1

1.2

22.75

16.58

u/ml

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

2.29

3.71

1.1

1.2

25.50

28.62

u/ml

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.90

3.63

1.1

1.0

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

827

3614

1.16

3.63

1.6

1.5

—

(3033099) Centromere Ab [Titer] in Serum

111

1.95

3.62

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.57

3.59

1.1

1.0

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

5.03

3.52

1.2

1.0

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

2127

9850

1.10

3.49

2.5

2.3

0.60

0.68

ug/l

2.00

1108

4128

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2.42

3.48

1.5

1.8

12.50

13.15

nmol/l

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

4.09

3.46

1.1

1.0

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

2.15

3.45

1.0

32.12

15.55

u/ml

0.44

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

123

430

1.44

3.37

2.6

2.1

8.90

10.31

mg/l

1.93

103

357

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

2.73

3.32

1.1

1.0

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.73

3.32

1.1

1.0

—

(3039443) Prostate specific Ag panel - Serum or Plasma

262

1660

0.79

3.31

1.4

1.5

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.65

3.31

1.7

1.8

—

(3018562) Neutrophils/Leukocytes in Cerebral spinal fluid

3.85

3.29

1.2

1.1

54.00

20.36

—

(3022640) Eosinophils/Leukocytes in Cerebral spinal fluid

5.03

3.24

1.2

1.1

0.20

0.00

—

(3037577) Monocytes/Leukocytes in Cerebral spinal fluid

4.02

3.19

1.2

1.1

4.43

6.00

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

227

887

1.29

3.12

1.1

3.62

1.98

u/ml

0.34

207

(3041672) Baker's yeast Ab [Presence] in Serum

2.32

3.11

1.1

1.2

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

213

826

1.30

3.10

1.7

1.2

387.22

2494.44

pmol/l

0.92

(3020874) Milk IgE Ab [Units/volume] in Serum

227

888

1.29

3.10

1.1

4.17

4.49

u/ml

0.03

261

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

108

375

1.45

3.09

1.8

2.0

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.87

3.05

1.0

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

4.57

3.03

1.1

1.2

—

(3015350) Toxocara sp Ab [Presence] in Serum

7.04

2.90

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

206

1.59

2.85

1.0

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

255

1.52

2.80

1.1

4.93

9.88

u/ml

0.44

171

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

207

1.58

2.80

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

207

1.58

2.80

1.0

—

(40758292) HTLV I+II Ab panel - Serum

130

1.74

2.78

1.3

1.2

—

(3020393) Adenovirus Ag [Presence] in Stool

2.19

2.78

1.6

1.2

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

326

1.45

2.75

2.1

1.7

118.87

115.70

au/ml

0.02

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.11

2.75

1.0

1.1

322.30

310.39

u/ml

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

237

1.53

2.71

1.2

1.1

9.61

5.67

u/ml

0.19

213

(3001729) Color of Synovial fluid

3.18

2.67

2.2

1.3

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

3.18

2.67

1.1

1.0

0.04

0.47

u/ml

0.47

(3009015) Lactate [Moles/volume] in Synovial fluid

2.51

2.61

1.2

5.37

6.09

mmol/l

—

(3036670) Protein [Mass/volume] in Synovial fluid

1.83

2.57

1.3

1.2

39.05

43.52

g/l

1.32

(3002523) Influenza virus A Ag [Presence] in Specimen

573

2511

1.15

2.54

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

628

0.71

2.52

3.0

3.3

—

(3003740) Influenza virus B Ag [Presence] in Specimen

572

2510

1.15

2.49

1.1

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

112

1.75

2.49

1.3

1.4

34.44

44.40

0.80

(3036071) Salmonella sp Ab [Titer] in Serum

296

1.45

2.48

1.1

—

(3013336) Amino acids [Identifier] in Serum or Plasma

3.25

2.45

3.9

4.2

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

213

855

1.25

2.45

1.1

0.84

1.13

u/ml

0.23

185

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

135

512

1.33

2.39

1.3

1.1

7.99

7.49

mm/h

0.26

135

512

(3005011) Chlamydia sp Ab [Titer] in Serum

110

1.74

2.37

1.4

1.3

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

216

0.53

2.31

1.1

1.50

1.20

mom

0.89

216

(3009871) Measles virus Ab [Titer] in Serum

276

1.44

2.29

1.7

2938.18

2816.84

titre

0.03

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

158

1.59

2.28

1.1

1.0

7.40

4.69

u/ml

0.69

158

(3032333) Phosphate [Mass or Moles] in 24 hour Urine

3.48

2.23

1.1

1.4

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

121

458

1.33

2.20

2.6

3.1

162.74

109.97

au/ml

0.41

(3025577) Chromium [Mass/volume] in Blood

140

1.62

2.20

2.1

2.3

1.87

2.81

ug/l

0.81

119

(3007542) Rye IgE Ab [Units/volume] in Serum

1.89

2.19

1.1

0.08

27.00

u/ml

0.50

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

133

1.63

2.15

1.0

0.26

1.42

u/ml

0.94

100

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

1.75

2.08

1.7

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

3.91

2.01

1.0

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

154

613

1.26

1.97

2.1

2.0

2.56

3.00

u/ml

0.18

205

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.91

1.97

1.1

1.0

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

150

1.54

1.90

1.0

1.1

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

2.51

1.88

1.0

1.56

5.48

u/ml

0.77

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

111

1.63

1.86

1.9

1.41

1.92

mg/l

1.26

(40759632) Porphyrins [Mass/mass] in Stool

5.03

1.82

1.2

1.0

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

133

527

1.27

1.80

3.3

4.0

8.98

9.62

mg/l

0.42

432

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

141

1.53

1.75

1.2

1.0

—

(3051101) Glucose [Moles/volume] in Cord blood

2.79

1.75

4.8

1.3

6.97

6.13

mmol/l

—

(3006598) pH of Arterial cord blood

2.41

1.75

1.1

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.68

1.73

1.0

1.1

0.47

0.14

u/ml

0.34

(3017937) Magnesium [Moles/time] in 24 hour Urine

3.77

1.73

1.2

1.1

—

(40762814) Titanium [Mass/volume] in Blood

2.04

1.72

2.4

2.8

3.02

6.13

ug/l

—

(3034614) HLA Ag [Interpretation]

2.65

1.70

1.2

1.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.32

1.63

1.2

1.1

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

602

0.78

1.59

6.5

7.0

8.57

8.49

0.05

602

(40761995) Spermatozoa Progressive [#/volume] in Semen

602

0.78

1.59

3.3

3.5

44.96

46.44

0.27

602

(3007919) Fasciola sp Ab [Titer] in Serum

2.93

1.56

1.0

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

150

1.48

1.54

1.0

0.56

0.77

u/ml

0.13

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

151

1.47

1.50

1.0

8.18

5.74

u/ml

0.10

(3022670) pH of Venous cord blood

2.39

1.45

1.1

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

3.02

1.43

2.3

1.8

24.73

27.32

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

284

1246

1.15

1.39

3.1

2.3

21.85

26.51

mg/l

1.51

177

789

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

133

1.47

1.39

1.1

0.37

1.68

u/ml

0.95

101

(3012989) Citrate [Moles/time] in 24 hour Urine

2.68

1.37

1.5

1.1

1.95

2.16

mmol/24h

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

109

1.52

1.36

1.1

10.34

8.06

u/ml

0.18

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.60

1.35

1.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

2.26

1.34

1.2

1.1

25.40

23.78

mg/24h

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

3.14

1.30

1.0

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

2.13

1.27

1.2

1.0

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.68

1.27

1.0

1.1

74.67

94.98

titre

0.78

(3011841) English Walnut IgE Ab [Units/volume] in Serum

137

1.43

1.23

1.1

0.97

2.95

u/ml

0.84

110

(3007700) Barley IgE Ab [Units/volume] in Serum

1.63

1.20

1.1

1.22

20.09

u/ml

0.45

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

105

1.48

1.17

2.8

2.6

3.69

3.78

mg/l

0.05

100

(3029612) Listeria sp Ab [Titer] in Serum

2.05

1.17

1.5

1.3

—

(42528597) U1 small nuclear ribonucleoprotein C Ab [Presence] in Serum by Line blot

2.79

1.17

1.0

—

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

2.79

1.17

1.0

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.71

1.11

2.1

1.2

271.47

303.22

umol/24h

0.39

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

352

1.23

1.00

1.1

—

(3016135) IgD [Mass/volume] in Serum

2.51

0.99

1.5

1.0

26.87

53.43

mg/l

—

(3001218) Citrate [Mass/time] in 24 hour Urine

2.07

0.99

1.4

1.2

356.00

488.06

mg/24h

—

(3046861) Legionella sp Ag [Presence] in Urine

2.07

0.99

1.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

263

1.26

0.98

1.1

41.36

23.42

iu/ml

1.44

263

(4211845) Urine protein measurement

295

1.24

0.96

2.3

1.9

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

2.12

0.94

1.1

35.94

27.51

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

145

1.35

0.94

1.1

1.0

1.48

0.51

u/ml

0.45

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

154

1.34

0.93

1.2

1.1

—

(40762887) Creatinine [Moles/volume] in Blood

2.01

0.92

1.5

1.1

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

1.91

0.89

4.3

6.4

0.27

0.22

mmol/l

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

1.91

0.89

1.1

64.66

58.93

—

(3018001) Oat IgE Ab [Units/volume] in Serum

1.42

0.84

1.0

0.07

1.33

u/ml

0.59

(3020650) Glucose [Presence] in Urine

287

1.23

0.84

2.0

1.3

0.00

estimate

-0.00

287

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.55

0.83

2.2

1.8

0.76

0.80

u/field

0.04

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.74

0.77

1.0

1.5

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

100

1.36

0.71

5.4

3.2

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

1.68

0.67

1.3

1.0

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

292

1352

1.09

0.67

1.4

1.5

6.75

6.16

mmol/l

2.91

265

1214

(3013762) Body weight Measured

1.68

0.64

1.4

1.0

—

(3034092) Cytoplasmic Ig cells/cells in Blood

103

1.32

0.61

7.7

2.6

0.16

0.18

0.38

103

(3006462) Nitrate [Presence] in Urine

264

1.18

0.57

2.2

1.9

—

(3033086) Enterovirus Ab [Titer] in Serum

1.68

0.57

1.0

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

470

2483

0.95

0.48

2.0

1.8

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

131

1.23

0.46

1.3

1.5

5.59

5.28

mmol/l

1.57

131

(3036312) Salmon IgE Ab [Units/volume] in Serum

1.34

0.44

1.0

1.1

3.62

1.77

u/ml

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

0.00

0.43

0.0

2.3

—

(3045759) Histamine [Moles/volume] in Serum or Plasma

0.00

0.43

0.0

1.3

—

(4133840) Spirometry

291

0.86

0.43

1.2

1.1

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.26

0.35

1.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

458

1.09

0.31

1.0

1.1

—

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

1.30

0.31

1.0

0.45

0.91

u/ml

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

138

649

1.07

0.29

1.2

1.3

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.82

0.23

1.0

1.1

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.22

0.0

1.4

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

1.31

0.21

1.2

1.0

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.16

0.20

1.1

1.2

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

119

571

1.05

0.17

1.2

1.4

1028.57

982.88

titre

0.13

111

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.75

0.16

1.3

1.1

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.76

0.15

1.1

7.19

8.34

mmol/l

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

103

540

0.96

0.13

1.4

1.5

5.50

4.96

mmol/l

4.99

518

(4038314) Semen analysis, post vasectomy

179

0.93

0.12

1.3

1.2

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

131

1.07

0.09

2.6

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.10

0.08

1.0

1.1

251.29

286.86

u/ml

—

(40765089) Chromosome analysis panel - Blood by G-banded

137

673

1.02

0.07

1.0

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

211

1079

0.98

0.07

1.5

1.4

32.16

36.15

nmol/l

0.97

187

1030

(3010937) Rubella virus Ab [Presence] in Serum

1.08

0.06

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.96

0.01

1.1

1.0

—

(3003157) Bacteria [#/volume] in Mother's milk

1.07

0.01

10.7

5.7

—

(3009677) Dengue virus Ab [Presence] in Serum

1.07

0.01

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

143

716

1.00

0.00

2.9

1.6

—

(3003577) Lead [Moles/volume] in Blood

103

1.02

0.00

1.3

1.6

0.86

0.51

umol/l

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

1.01

0.00

1.0

1.1

0.01

1.32

u/ml

—

(3027114) Cholesterol [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint ANTIDEPRESSANTS and mortality.

Females

Parameter	HR [95% CI]	p-value
ANTIDEPRESSANTS	1.488 [1.39, 1.6]	< 0.001
Birth year	0.991 [0.98, 1.0]	0.031

During the follow-up period (1.1.1998 — 31.12.2019), 103249 out of 611724 females with ANTIDEPRESSANTS died.

Males

Parameter	HR [95% CI]	p-value
ANTIDEPRESSANTS	1.798 [1.66, 1.95]	< 0.001
Birth year	0.981 [0.97, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 79482 out of 387224 males with ANTIDEPRESSANTS died.

Mortality risk

Mortality risk for people of age

years, who have ANTIDEPRESSANTS.

N-year risk	Females	Males
1	0.079%	0.249%
5	0.594%	1.465%
10	1.431%	3.877%
15	2.817%	7.036%
20	5.127%	11.528%

Relationships between endpoints

↥

Index endpoint: ANTIDEPRESSANTS – Depression medications

GWS hits: 56

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Depression medications

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints